Defining the human endothelial transcriptome by Natarajan, Sripriya, 1978-
Defining the Human Endothelial Transcriptome
by
Sripriya Natarajan
M.Eng. Electrical Engineering and Computer Science
Massachusetts Institute of Technology, 2001
S.B. Computer Science and Engineering
Massachusetts Institute of Technology, 2000
SUBMITTED TO
THE HARVARD-MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF
MASTERS OF SCIENCE IN HEALTH SCIENCES AND TECHNOLOGY
AT THE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
MASSAHETSi-NS'TT7E-
OFTECHNOLOGYJUNE 2005 I
JUN 3 0 2005
© 2005 Sripriya Natarajan. All rights reserved. LIBRARIES
The author hereby grants to MIT permission to reproduce
and to distribute publicly paper and electronic
copies of this thesis document in whole or in part.
Signature of Author: ... .........................................
Harvard-MIT Divison of Health Sciences and Technology
March 18, 2005
Certified by: ...........................C ertified by: ........................... .............................................................................................Guillermo Garcia-Cardefia, Ph.D.
Assistant Professor of Pathology, Harvard Medical School
Thesis Supervisor
Accepted by:............................M artha L.......................................................................
'~- j Martha L. Gray, Ph.D.
Edward Hood Taplin Professor of Medical Egineering and Electrical Engineering, MIT
Co-director, Harvard-MIT ivision of Health Sciences and Technology
.ARCH1v6
Defining the Human Endothelial Transcriptome
by
Sripriya Natarajan
Submitted to the Harvard-MIT Division of
Health Sciences and Technology
on March 18, 2005 in Partial Fulfillment of the
Requirements for the Degree of Master of Science in
Health Sciences and Technology
ABSTRACT
Advances in microarray technology facilitate the study of biological systems at a
genome-wide level. Meaningful analysis of these transcriptional profiling studies, however,
demands the concomitant development of novel computational techniques that take into account
the size and complexity of the data. We have devised statistical algorithms that use replicate
microarrays to define a genome-wide expression profile of a given cell type and to determine a
list of genes that are significantly differentially expressed between experimental conditions.
Applying these algorithms to the study of cultured human umbilical vein endothelial cells
(HUVEC), we have found approximately 54% of all genes to be expressed at a detectable level in
HUVEC under basal conditions. The set of highest expressed genes is enriched in nucleic acid
binding proteins, cytoskeletal proteins and isomerases as well as certain known markers of
endothelium, and the complete list of genes can be found at http://vessels. bwh.harvard. edu/
software/endo_xcriptome . We have also studied the effect of a 4-hour exposure of HUVEC to
10 U/mL of IL-], and detected 491 upregulated and 259 downregulated statistically significant
genes, including several chemokines and cytokines, as well as members of the TNFAIP3 family,
the KLFfamily and the Notch pathway. Applying these rigorous statistical techniques to
genome-wide expression datasets underscores known patterns of endothelial inflammatory gene
regulation and unveils new pathways as well. Finally, we performed a direct comparison of
direct-labeled microarrays with amplified RNA microarrays for an initial assessment of the
effect of the additional noise of amplification on the outputs of the statistical algorithms. These
techniques can be applied to additional genome-wide profiling studies of endothelium and other
cell types to refine our understanding of transcriptomes and the gene regulatory network
governing cellular function and pathophysiology.
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Title: Assistant Professor of Pathology, Harvard Medical School
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1. Introduction
1.1. Gene Microarray Technology
Gene microarray technology now allows biologists to assay the transcriptional activity of
tens of thousands of genes simultaneously [1-3]. The combination of this technology with the
sequencing of the human genome has led to the development of total genome microarrays that
allow systems biologists to view the comprehensive transcriptional activity of a cell or tissue
type [4-6]. These total genome datasets possess a degree of richness that allows complex cellular
regulatory mechanisms to be studied at a new level of detail.
These large datasets, however, also pose a myriad of analytical challenges. Data for over
30,000 genes, comprised of hundreds of thousands of individual data points, must be organized
in a meaningful manner. In addition, for any given gene and condition, there are usually three
replicates, and given the signal-to-noise characteristics of most microarray platforms, creative
approaches must be used to analyze the data in a useful, statistically rigorous manner. Yet, when
these aspects are taken into account, there is a vast potential for mining these datasets to uncover
new biology.
1.2. Genome-wide Transcriptional Analysis of Endothelium
Vascular endothelium comprises a dynamic interface between blood and the vascular
wall. Their intact function is essential for the regulation of many vital responses, including
inflammation, haemostasis and vasodilation/constriction. Although this cell type is ubiquitous, it
is far from being homogenous; for example, endothelial cells in the pulmonary, cardiac and brain
microvessels [7] and the high endothelial venules of lymphoid tissue [8, 9], are specialized to
cater to the special needs of their organs. Arterial and venous endothelial cells throughout the
body have different morphologies, protein synthesis and levels of permeability [10, 11].
Discovering the similarities in the expression profiles between different endothelial cells will
help us to define the set of genes required for basic endothelial identity. Determining the
differences between these profiles will help elucidate which pathways confer the unique
properties of specialized endothelial cells. In addition to developmental differences, a wide array
of environmental factors can also affect endothelial cell phenotype; cytokines, hormones,
metabolic products, hydrostatic pressures and flow-induced shear stress all modulate endothelial
function [12, 13]. Studying the genome-wide transcriptional changes caused by such external
stimuli can shed light on the regulatory mechanisms governing endothelial cell structure and
function.
Our laboratory has recently embarked on an effort to extend our transcriptional profiling
studies of endothelium [14, 15] by applying total genome microarray technology. Our recent
foray into analyzing the transcriptional activity of endothelial cells at a global level has been
enabled by a single-channel microarray platform containing 33,096 probes representing the
entire genome of 29,791 genes, based on 60,808 transcripts. The ability to collect data
simultaneously in such a comprehensive manner allows us to explore the transcriptional biology
of endothelium in novel ways. Most immediately, the ability to assess the expression level for
every gene allows us to define a putative endothelial transcriptome-the set of genes that are
required for endothelial identity and are expressed at some detectable level under standard
culture conditions. We can then assess how this global expression profile changes under
different relevant stimuli. As data is collected for additional experimental conditions, we will be
able to begin to decipher the complex gene regulatory networks governing endothelial function.
This study has developed computational techniques to define global expression profiles
and to detect differential expression between profiles. We demonstrate the efficacy of these
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techniques by defining the genome-wide expression profile for cultured human umbilical venous
endothelial cells (HUVEC) and studying the changes caused by a potent inflammatory stimulus,
IL-1. IL- was chosen as the first stimulus to examine because it has been previously well
characterized and yet has been known to involve several pathways [16], thus increasing the
potential for the discovery of new genes regulated in endothelium.
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2. Genome-wide Expression Profile of Cultured HUVEC
2.1. Two-Population Hypothesis of Gene Intensity Distribution
Determining which genes are expressed in a given cell type under a set of standard
control conditions sheds light on the genes that are required for the basic function of that cell
type. Biologically, the question posed is: under defined baseline conditions, which subset of
genes from the human genome are "turned on" or expressed, and which are the remaining genes
that are "turned off' or not expressed. When microarray data is to be used to determine gene
expression levels, the corresponding computational question becomes: what signal intensity
corresponds to a gene transcript being expressed above noise levels?
Consider the distribution of intensity signal values (Fig 2.1a); i.e., the frequency at which
signal values are observed among all the spots on a single microarray for different small ranges
of signal values. This frequency corresponds to p(x), the probability of a random spot's intensity
having a value of x. Given the biological premise that any gene falls into one of two categories,
expressed or non-expressed, this distribution is actually comprised of two separate
distributions-pE(x), the probability distribution of intensity values for a randomly selected spot
detecting an expressed gene and PN(X), the probability distribution of intensity values for a
randomly selected spot detecting a non-expressed gene. The net probability distribution, p(x), is
a weighted sum of the two individual distributions, f* PN(X) + (1-f)* PE(x), where f is the
fraction of spots detecting non-expressed genes (Fig 2.lb).
This proposed mixed distribution is supported by the skewed shape of the net frequency
distributions shown in Fig. 2.la; the left tails resemble Gaussian distributions, which are
commonly occurring distributions for noise (i.e., "signals" of spots probing non-expressed genes,
that are caused by non-specific hybridization, instrument measurement error, etc.), but the right
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Fig. 2.1. (a) Histogram of signal intensities for three independent replicate
microarrays of cultured HUVEC. (b) Theoretical signal distributions of
expressed and non-expressed spots and the net distribution generated by their
sum. (c) Theoretical net signal distribution and actual signal distribution for
replicate #1. The dashed line indicates the cutoff signal value for expressed
genes that maximizes the theoretical true classification rate.
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tails fall off much more gradually. We hypothesized that this net distribution could be
decomposed into a non-expressed Gaussian distribution (gray line, Fig. 2.lb) and an expressed
distribution, which we modeled as a shifted log-normal distribution (red line, Fig. 2.lb). (A log-
normal distribution implies that the logged values of the signal intensities follow a Gaussian
distribution.). These two separate distributions could then be used to determine appropriate
cutoffs for classifying a spot as representing an expressed on non-expressed gene.
2.2. Experimental Methods
2.2.1. Cell culture. Consistent culture conditions are important to generate a reliable
gene expression profile of HUVEC since several factors such as cell cycle point, age, passage
number, confluency or media can affect transcription. HUVEC were isolated from normal term
cords and pooled from 5 to 7 donors were cultured in complete media supplemented with 20%
fetal calf serum, 2mM L-glutamine, 50 mg/ml endothelial cell growth supplement, 100 mg/ml
heparin and 100 unit/ml penicillin-G1100 mg/ml streptomycin, and incubated at 370C in 5%
C02 in humidified air. Cells from the first subculture were plated at an initial density of 70,000
cells/cm 2 and grown for 24 hours, a time point at which we have documented that only 4-6% of
the cells are in G2M phase [14]. Fresh media was added at this time point and cells were
collected 4 hours later.
2.2.2. RNA isolation and purification. Cells were rinsed twice with PBS before
collection, then scraped into Trizol. Total RNA was isolated by using TRIzol reagent
(Invitrogen, Carlsbad, CA) and the RNeasy kit (Qiagen, Valencia, CA). Total RNA was DNase-
treated with the RNase-free DNase kit (Qiagen) according to the manufacturer's protocol and
purified on RNeasy mini columns (Qiagen). RNA quality was verified by Agilent's 2100
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Bioanalyzer with RNA 6000 Nano LabChip Kit. The concentration of RNA was measured by
spectrophotometric analysis at 260 nm.
2.2.3. Microarray preparation and scanning. Labeling, hybridization and scanning were
performed according to the manufacturer's protocols for the AB 1700 microarray scanner using
total human genome microarrays (Applied Biosystems, Foster City, CA), with 30,096 spots
representing 28,790 different genes. Each spot uses a 60 base pair probe that represents a region
within the first 1500 base pairs of the 3' end of the target mRNA. Briefly, 40 ptg of purified total
RNA for each sample was used in an RT reaction that incorporated digoxigenin label into the
cDNA products. The cDNA was then purified using a DNA purification column, DNA wash
buffer and DNA elution buffer supplied by the manufacturer. Purified cDNA was then
hybridized at 55°C under agitation at 100 rpm for 16 hours, to a glass microarray slide that was
pre-hybridized with AB1700 Blocking Reagent for 1 hour. Slides were then washed as per
manufacturer's protocol, then incubated under agitation with anti-digoxigenin-AP antibody for
20 minutes. Microarrays were then treated with a Chemoluminescence Enhancing Solution.
Finally, the chemoluminescence substrate was added and the array scanned within one hour.
2.3. Methods for Decomposing Spot Intensity Distribution
2.3.1. Recovery of negative intensity values. The Applied Biosystems 1700 microarray
processing software quantifies the spot intensities from two images, one capturing the
chemoluminescent signals from the top half of the microarray and the other capturing the
chemoluminescent signals from the bottom half of the microarray. The software then performs a
number of normalization steps on the image quantification data. First, the chemoluminescent
signal from each spot is subtractively corrected with a control fluorescent signal. This correction
procedure can result in negative values for very dim (i.e., non-expressed) spots, which are
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necessary to observe the true Gaussian nature of the noise distribution. The software, however,
maps negative and other low-valued spots to a positively valued surrogate, the standard deviation
of the different individual pixel values for the spot. The fluorescent-corrected and surrogated
values are then normalized to map into a standard dynamic range of values, so that different
arrays can be compared to one another meaningfully. This normalization step produces a
different normalization factor for each spot, but the correction factors for the spots from the same
region (top image or bottom image) are very similar. Thus, in order to generate normalized but
unsurrogated intensity values, first the normalization factors from all spots that were not
surrogated were averaged to generate a single uniform normalization factor for each region.
Then the pre-normalized signal-to-noise ratio for each spot was multiplied by the inter-pixel
standard deviation to recover the unnormalized, unsurrogated signal value, which was finally
multiplied by the appropriate average normalization factor. This technique maps intensities to an
appropriate dynamic range while preserving negative values. Spots flagged as poor quality (flag
> 10,000) were excluded from analysis.
2.3.2. Net frequency distribution of signal intensity values. Three microarrays, each
representing an independent biological replicate of HUVEC cultured under the conditions
described above, were used to develop a baseline endothelial expression profile. The frequency
of occurrence of normalized, unsurrogated signal values was counted using bin sizes of 0.1
intensity units, centered from -5.0 to 4500.0. The frequency distributions were calculated for
each microarray separately. Figure 2.la illustrates that the three distributions are highly similar
to each other, with the squared Pearson's linear correlation coefficient (R2) between any two
replicates being 0.99.
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2.3.3. Decomposition of net frequency distribution. The net frequency distribution was
modeled as p(x) = f* PN(X) + (-f)* PE(X), i.e., the weighted sum of a Gaussian distribution,
PN(X) = 7 e-(X N)2 /(2aN ) , where the mean, JAN, and standard deviation, N are adjustable
1 e (ln(x X) HE)2 /(2E )2 parameters, and of a shifted log-normal, PE(X) = e- n ° ) ,where the
X , where the
mean, ,gN, and standard deviation, N and shift, x0o, are adjustable parameters. In addition, the
relative fraction of the two distributions, f, is also an adjustable parameter. The associated
cumulative distribution function for p(x) was used to determine the probability p(xl < x < x2) for
each bin ranging from xl to x2. The error between the actual and theoretical distributions was
calculated as the sum of the squared differences between the actual frequency of occurence and
theoretical cumulative probability for each bin. Starting with initial values of f= 0.5, ,UN=O,
oN=0.5 , gE=l, (N=l and xo=0.5, and applying the constraint that x0 > N+CN, Microsoft Excel
Solver, which applies the Generalized Reduced Gradient (GRG2) Algorithm for optimizing
nonlinear problems [17], was used to determine a set of parameter values that minimized the
error. This analysis was performed separately for each of the three replicate arrays. The final
parameter values and root mean square (RMS) error (square root of the mean squared error
across bins) are given in Table 2.1. The theoretical (dashed blue line) and actual (solid black
line) distributions for the first replicate are shown in Fig. 2. lc, illustrating that the two curves are
extremely similar.
2.3.4. Selecting a cutoff for classification of spots as expressed or not expressed. The
two distributions, as seen in Fig. 2.lb, overlap with one another; thus any intensity cutoff used to
classify spots as expressed or non-expressed will generate a certain number of false positives and
false negatives. We generated ROC curves, shown in Fig. 2.2a, that graph the theoretical
12
Replicate #1 #2 #3
Minimum signal value -2.70 -1.66 -3.68
Maximum signal value 3245.93 3535.44 4429.74
f 0.38 0.37 0.40
0.06 0.02 0.06
oN 0.17 0.17 0.21
1.62 1.61 1.73
aE 2.09 2.02 2.04
x0 0.30 0.20 0.38
RMS Error 6.9E-03 1.OE-02 6.8E-03
ML Cutoff 0.35 0.31 0.44
True Classification
Rate 98.5% 96.6% 97.7%
Table 2.1. Statistics andparameter valuesfor two-populationfit of signal
intensity distributionsfrom 3 replicate microarrays of cultured HUVEC RNA.
sensitivity (true positive rate) vs. 1-specificity (false positive rate) for a range of cutoff values, to
demonstrate the effect of choosing different cutoff values. That the ROC curves lie close to the
left and upper borders of the graph indicate that the two distributions are well separated despite
their overlap, and that a cutoff with low false classification rates can be selected.
One must therefore select a cutoff that meets some desired criteria for the false
classification rates. For example, to reduce the false negative rate to 0, one should choose a
cutoff c < x0, guaranteeing that every spot belonging to the log normal (expressed) distribution
will be classified as expressed; the tradeoff is, of course, a very high false positive rate. The
other extreme choice to reduce the false positive rate to 0 by choosing a cutoff c >> N + 4 N,
which lies far into the right-hand tail of the Gaussian (non-expressed) distribution; the tradeoff in
this case would be a very high false negative rate. A more balanced option is to choose a cutoff
c that maximizes f*pN(X<C)+(1-f)*pE(x>c), the theoretical net true classification rate. A fourth
option is to choose the cutoff to be the pth percentile of all values, so that the highest (l-p)% of
spots are classified as expressed. Fig. 2.2b demonstrates the different theoretical true positive,
13
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Fig. 2.2. (a) Receiver operating curve (ROC) plotting the theoretical sensitivity
vs. -specificity for different cutoffs. Data shown for all three replicates. (b)
Changes in theoretical true positive, negative and net classification rates as
cutoffs are varied for replicate #1.
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true negative and net true classification rates for a range of cutoffs, using the theoretical
distribution fits for replicate #1.
We chose to use a cutoff for each array that maximized the theoretical net true classification
rate. The cutoff and corresponding theoretical true positive and true negative rates for each array
are given in Table 2.1. Finally, we selected spots that were classified as expressed on all
replicates of good quality (for most spots there were 3 good quality replicates) to generate a list
of expressed genes in quiescent cultured HUVEC, which included 18,472 (56%) spots
representing 16,026 (54%) genes.
2.4. Patterns of gene expression in cultured HUVEC
2.4.1. Chromosome distribution. Fig. 2.3a shows the physical chromosome location of
all annotated genes on the array in red and Fig. 2.3b shows the location of all expressed genes on
the array in blue. HUVEC appear to express genes found on every single chromosome, and no
regions appear to be enriched in expressed genes compared to the chromosomal distribution of
all annotated genes.
2.4.2. Functional categorization of expressed genes. One of the most tractable ways of
analyzing this genome-wide expression profile for cultured HUVEC is to group expressed genes
by their function. One of the most widely used functional categorizations of genes is the Panther
system [18]. The detailed Panther molecular function categories were partially merged to
generate broader categories and the "molecular function unclassified" category was removed;
these simplified categories are given in Table 2.2. Of the 33,096 spots on the array, 14,993
(45%) spots-representing 12,550 out of 29,791 (42%) genes-were associated with one or
more simplified Panther categories. Of the expressed genes, 8,060 out of 16,207 genes
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Fig. 2.3. (a) Plot showing chromosomal location of annotated genes on microarray.
Bar height corresponds to relative number of genes in given location. (b) Plot
showing chromosomal location of annotated genes on microarray that were also
classified as expressed.
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Fig. 2.4. Histogram illustrating the total number of genes on the array (gray) and
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No. of No. of Percentage Percentage
ofSimplified Panther Function Genes Genes of Category ExpressedExpressed
on Array Expressed Enrichment Genes
Nucleic acid binding 1769 1559 88.1%/ 9.7%
Transcription factor 1674 1208 72.2% 7.5%
Cytoskeletal protein 730 484 66.3% 3.0%
Kinase 621 461 74.2% 2.9%
Oxidoreductase 614 412 67.1% 2.6%
Transferase 575 401 69.7%/ 2.5%
Myelin protein 476 366 76.9% 2.3%
G-protein 484 357 73.8% 2.2%
Hvdrorlase 491 322 65.6% 2.0%
ransporter 485 277 57.1% 1.7%
Protease 467 273 58.5% 1.7%
Receptor 633 243 38.4% 1.5%
Membrane traffic protein 309 237 76.7% 1.5%
Phosphatase 251 184 73.3/ 1.1%
Synthase and synthetase 196 163 83.2% 1.0%
Liase 1 18C 48 82.2% 0.9%
Cell adhesion molecule 299 132 44.1% 0.8%
G-protein coupled receptor 642 129 20.1% 0.8%
Chaperone 147 128 87.1% 0.8%
Signaling molecule 229 127 55.5% 0.8%
Defense/immunity protein 458 124 27.1% 0.8%
Isomerase 124 117 94.4%/ 0.7%
Transfer/carrier protein 194 116 59.8% 0.7%
Extracellular matrix 229 105 45.9% 0.7%
Lyase 142 97 68.3% 0.6%
Kinase modulator 117 91 77.8% 0.6%
Ion channel 280 78 27.9% 0.5%
Structural protein 173 78 45.1% 0.5%
Select calcium binding protein 146 74 50.7% 0.5%
Protein kinase receptor 105 69 65.7% 0.4%
Membrane-bound signaling molecule 116 68 58.6% 0.4%
Cytokine receptor 81 49 60.5% 0.3%
Cell junction protein 84 47 56.0% 0.3%
Cytokine 132 46 34.8% 0.3%
Protease inhibitor 101 37 36.6% 0.2%
Transmembrane receptor regulatory/adaptor protein 58 37 63.8% 0.2%
Select regulatory molecule 39 32 82.1% 0.2%
Phosphatase modulator 38 28 73.7% 0.2%
Growth factor 71 26 36.6% 0.2%
Peptide hormone 82 24 29.3% 0.1%
Storage protein 23 16 69.6% 0.1%
Chemokine 40 15 37.5% 0.1%
Other enzyme regulator 18 11 61.1% 0.1%
Miscellaneous function 6 6 100.0% 0.04%
Viral protein 8 3 37.5% 0.02%
Surfactant 12 1 8.3% 0.01%
Table 2.2. Summary of simplified Panther classifications for
annotated genes determined to be expressed in cultured HUVEC.
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associated with one or more simplified functional categories. The number of expressed genes
compared to the total number of genes on the array for each category is shown in Fig. 2.4.
Table 2.2, which gives the number of expressed genes as a percentage of the number of
genes on the entire array for each category, indicates that genes from every simplified category
are classified as expressed in cultured HUVEC. Of especial note are the nucleic acid binding,
chaperone and isomerase categories, which are enriched by over 85%.
We examined the top 5% of expressed genes, ranked by average intensity, to study which
genes were the most highly expressed. (A list of all expressed genes, their average intensities
and percentiles can be found at http://vessels.bwh.harvard.edu/software/endo_xcriptome .) A
remarkable 57% of these genes were classified as related to nucleic acid binding. 422 of these
genes were ribosomal, ribonuclear or other RNA-binding proteins, 23 were translation initiation
or elongation factors and 6 were histones, DNA helicases or chromatin-binding proteins. In
addition, 4% of the highest expressed genes coded for cytoskeletal proteins, mostly tubulin and
actin-related, and another 4% of these genes coded for isomerases. Thus, rather than being
endothelial-specific, the highest expressed genes are mostly related to the function of any
transcriptionally active cell, and we would expect to see most of these genes expressed at high
levels for most other cultured cell types.
However, certain genes known to be crucial for endothelial function and identity were
also found within the top 5% of expressed genes, including PECAM/CD31 and Hsp-90 protein 1
alpha and beta. PECAM is considered to be an endothelial cell-surface marker, also plays an
important role in regulating endothelial permeability, cell signaling and cell survival [19].
Hsp90 associates with and activates eNOS, the most important vasodilatory molecule produced
by endothelial cells [20]. Other highly expressed genes-within the top 15% of expressed
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genes-include vonWillebrand factor, a molecule important in hemostasis that is found in
endothelial-specific Weibel-Palade bodies and may be a shear-stress sensitive molecule [21] and
reticulon 4/NOGO, which is a regulator of vascular remodeling [22].
A number of vasoactive proteins in addition to Hsp90 are expressed at high levels. These
genes include caveolin-1, which has been shown to be prominent in vascular endothelium [23] as
well as caveolin-2, both of which binds and disables eNOS [24], and endoglin, which
upregulates eNOS protein expression [25]. Suprisingly, eNOS itself is expressed, but at
approximately the 45th percentile of expressed genes, a lower level than some of its regulators.
Several genes from the endothelin pathway, the most important vasorestrictive system in
endothelial cells[26], are also expressed, including endothelin-1, as well as endothelin converting
enzyme 1 [27] at high levels and endothelin converting enzyme 2, shown to be expressed
previously in HUVEC [28], at lower levels (intensity of 1.3, 1 5th percentile of expressed genes).
Surprisingly, the endothelin receptor B, the chief endothelin receptor for endothelial cells [29], is
expressed in cultured HUVEC, but at a very low level (average intensity -0.50, 0 .7th percentile
of expressed genes). If this result is true, it suggests that perhaps the receptor's turnover from
the cell surface membrane is low. Other vasoactive factors that are expressed in HUVEC include
ACE-1 and 2, and adrenomedullin.
The Notch pathway, initially known for its role in neuronal development, has been shown
to play an important role in vascular development [30, 31] and injury response [32]. Several
genes involved in this pathway were found to be expressed in cultured HUVEC, including notch-
1, 2 and 3 homologs, delta-like 1, 3 and 4, deltex 2 and 3, jagged 1 and 2 (jagged 1 among the
top 15% of genes), presenilin-1 and 2 and suppressor of hairless. Two transcription factors
downstream of suppressor of hairless [33] were also expressed in cultured HUVEC at
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appreciable levels, HEY-1 and HEY-2. HEY-2 is considered to be important in embryonic
vascular development [34] and may also be an arterial-specific marker [35].
A variety of other transcription factors known to play an important role in endothelial
function were shown to be expressed in cultured HUVEC through our analysis. Several
members of the Kruppel-like factor family, KLF-2, 3, 5, 7, 14, 15 and 16 are expressed, the
highest of which is KLF-2, which appears to be a anti-inflammatory and pro-vasodilatory
transcription factor in endothelial cells [36]. Three myocyte enhancing factors, MEF2A, C and
D, were all shown to be expressed. MEF2A has recently been implicated as an endothelial gene
whose mutation causes inherited cardiovascular disease [37].
Those transcription factors whose roles are not well characterized in endothelium include
several members of the foxhead box family, which may play a role in regulation of cell
proliferation of HUVEC [38], the dachshund homolog, which has been shown to play an
important role in optic development [39], as well as several jumonji family genes that are
thought to have a role in neural development [40] but are not further characterized in mammalian
systems. The expression of these transcription factors in endothelium may provide further
insight into their transcription factors.
The pattern of expression of arterial and venous markers in cultured HUVEC is
extremely interesting. A number of Ephrins (A1-5, B 1 and 2) and their Eph receptors (EphA2
and 4, B 1, 2, 4 and 6). The highest expressed of these, Ephrin B2, a putative arterial marker, and
EphB4, a venous marker [41], are both expressed at similar levels (over the 75th percentile
among expressed genes). Expression of both these molecules together is generally not seen after
development. Interestingly, cultured HUVEC appears to express other markers of both veins and
arteries, such as HEY-2 and neuropilin 1, which are arterial, and Tie-2 and neuropilin 2, which
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are venous [30]. This dichotomy may be explained by the unique physiological role of HUVEC
since the umbilical vein receives low flows but oxygenated blood, and is meant to atrophy after
birth. It may also be a result of phenotypic drift after being cultured.
Several endothelial development and angiogenesis-related genes are also expressed in
cultured HUVEC. Among these are tissue inhibitor of metalloproteases 2, which is one of the
top 5% of expressed genes, thought to mediate inhibition of angiogenesis [42], and angiopoietin-
2, among the top 15% of expressed genes, known to control the ratio of arterial/venous vessels
during angiogenesis [43]. Among the 20 collagens that are expressed in cultured HUVEC, the
two highest expressed are collagen IVa2, the primary component of basement membranes,
which would be important for newly plated HUVEC to lay down, and collagen XVIIIa , whose
C-terminal fragment is endostatin, a potent anti-angiogenic factor [44]. IL-8, which is both a
chemokine and an angiogenic stimulus [45], is also expressed appreciably in cultured HUVEC.
The role of these genes under these circumstances could be an influence of culture conditions, or
these genes could possibly play other important roles in endothelial function outside of their
angiogenic roles. For example, VEGF-A (expressed at low levels) and VEGF-B and C
(expressed at higher levels) are considered to be pro-angiogenic factors, but they also play a role
in mediating endothelial permeability.
Endothelial cells play an important role in regulating inflammatory responses. The genes
regulating this function would most likely not be expressed until the cells were exposed to an
inflammatory stimulus, but surprisingly, two adhesion molecules known to be induced by
inflammatory conditions, E-selectin and VCAM, both have intensities above the 3 0 th percentile
of expressed genes. These genes may be false positives, or alternatively, may indeed be
expressed at extremely low basal levels in quiescent conditions. Over 35 MAP kinases and MAP
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kinase-related proteins, which are known to be important in the signaling pathways triggered by
inflammatory responses [46], were found to be expressed basally, presumably primed for being
activated by upstream factors in the case of an inflammatory response.
Several genes involved in hemostasis, which is closely linked to the inflammatory
response, appear to be expressed in cultured HUVEC, including calmodulin, which is among the
top 5% of expressed genes and is involved in von Willebrand factor-dependent shear-induced
platelet aggregation [47], and thrombomodulin, which is an anti-thrombotic factor. Culture
conditions that do not mimic the blood flow endothelial cells see in a physiological setting could
affect the expression of hemostatis-related genes.
Interestingly, the expression data supports recent hypotheses regarding endothelial
function. For example, tight junctions, thought to be primarily an epithelial feature, have
recently been shown to exist in dermal microvascular endothelium [48]. Our data show that
several genes involved in tight junction formation are among the highest expressed genes in
HUVEC, including connexin 43 (in the top 6% of expressed genes) as well as ECAM, zona
occludens 1 and 2 (in the top 20%). Another hypothesis sparking much discussion is the
possible role of endothelial cells as professional antigen presenting cells. They have been shown
to play such a role in the liver [49] and small intenstine [50], but whether endothelial cells play
this role in a generalized fashion is still under debate. A few MHC class II genes, coding for the
molecules used by professional antigen-presenting cells, are expressed in cultured HUVEC, the
highest of which was HLA-DPA1 (average intensity 10.2, approximately 6 0 th percentile of
expressed genes). A similar number of MHC class I genes were also expressed, but at higher
levels (65th to 9 0 th percentiles). Studies have shown that the development of the vascular and
neural system are linked. Interestingly, several of the genes expressed in cultured HUVEC are
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well known for their neural role, such as neuropilin-1 and 2 [51], neurexin-2, a neural cell
surface protein [52] and adrenomedullin and MEF2A, both of which influence neuronal
differentiation [53, 54].
2.5. Caveats of Expression Profile Analysis
A total-genome microarray system allows one to examine the entire pattern of gene
expression across the genome, and provides new data to estimate how many genes are expressed
in a typical mammalian cultured cell type. Our estimate of approximately 16,000 genes is about
50% greater than previous estimates of approximately 10,000 genes in an endothelial-derived
cell line [55]. Several factors could contribute to this difference. For one, our analysis does not
necessarily exclude genes that may have only a few transcript copies; we seek only to distinguish
between signals due to measurement noise and signals due to specific hybridization. We also
make the assumption that the noise level is identical for every gene, when in fact the binding
properties of each probe may be slightly different; a signal level of 1 may indicate specific
hybridization for one probe while it may represent non-specific hybridization for another probe.
Finally, the results are highly dependent on the choice of distributions. We have made the
assumption that the noise distribution itself is a symmetric Gaussian; if this noise distribution
itself is actually skewed towards the right, then our assumption would be generating additional
false positives. However, the strong matching between the theoretical and actual distribution
well, as seen in Fig. 2.lc, supports the use of the current choice of distributions.
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3. Statistical Detection of Regulated Genes Using Intensity-Based Variance
Estimation*
3.1. Statistical Methods for Detecting Differential Expression from Gene Microarray Data
3.1.1. The Necessity for Statistical Detection of Differential Expression. Biologists can
now use microarray technology to determine the expression levels of tens of thousands of genes
simultaneously, in less time than it previously took to measure the expression level of a single
gene. However, there remains the challenge of processing the microarray data from array images
into a format that best facilitates the discovery of new biological insights. The potential of gene
microarray technology is limited without an estimate of the statistical significance of the
observed changes in gene expression. Algorithms beyond standard statistical methods, such as
the Student's t-test, are necessary to produce reliable results. We strongly believe, as do others,
that the quality of the data processing steps is critical to the overall success of a microarray
experiment [56].
A typical data processing pipeline consists of several steps. (See [57] for a review, and
see [58, 59] for a review of microarray processing software.) First, image analysis software
locates the arrayed spots in the scanned image, quantifies the foreground and background
brightness of each spot, and notes any irregularities in spot morphology. The background
intensity value is then subtracted from the foreground intensity value. The background-
subtracted intensity data from each array must then be normalized, or rescaled, to remove
artifactual differences in signal brightness due, for example, to different labeling efficiencies that
produced arrays of different overall intensity. Normalization techniques are often based on the
assumption that a large number of spots will have similar expression levels between conditions.
*This chapter is modified from Comander, J.*, Natarajan, S.*, et al. BMC Genomics. 2004 Feb 27;5(1):17 (* equal
contributors).
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Curve-fitting techniques, such as a locally weighted regression, are used to equalize expression
values between arrays, or between array channels for two-color arrays [60, 61]. After this
normalization, the intensity values can be used by a variety of algorithms for detecting
differences in expression between the measured biological conditions. This processing is applied
whether two samples are compared directly or a "reference sample" experimental design is used.
In a reference sample design, the same reference RNA sample is hybridized to one channel of all
arrays, and the other channel is hybridized with each individual experimental sample. This
design is often used when multiple biological conditions are being investigated and it becomes
impractical to perform every pairwise combination of conditions directly [57, 62].
Given a list of normalized intensity values across various biological conditions, the next
step is to determine which genes are differentially regulated among the conditions being studied.
In the early days of microarray experimentation, an emphasis was placed on analyzing the data
using exploratory data mining techniques, such as hierarchical clustering [63] and self-
organizing maps [64]. Clustering algorithms measure the similarity between observed gene
regulation patterns across the various conditions, and assemble clusters such that similarly
regulated genes are grouped together. The resulting clusters produce an effective overview of
the data, showing which of the many possible patterns of regulation are actually present in the
data. Since these patterns are somewhat robust, a few erroneous spots are unlikely to change
them dramatically. For a researcher who is simply interested in the overall pattern of the data,
performing replicate arrays to reduce the number of errors is not particularly efficient. Many
researchers choose instead to explore a greater number of experimental conditions.
Increasingly, microarrays are being used in a different context; researchers want to know
with high confidence which specific genes are regulated across a small number of experimental
26
conditions (e.g., treatment vs. control, or mutant vs. wildtype). To answer this question, it
becomes extremely important to use an accurate method to rank individual genes by their
probability of truly being regulated, especially since this information may be used to plan more
labor-intensive experiments around biological questions raised by a small number of such
putatively regulated genes. In the absence of replicate arrays, the reliability of the data can be
estimated (e.g. [65], [66]), but such "single slide" methods require a model of the expected noise
characteristics of the system, a property that can potentially change between datasets.
Performing replicate arrays can significantly improve predictions of differentially regulated
genes, thereby decreasing the false positive (false detection) rate and false negative rate [62, 67,
68]. Using replicate arrays allows the calculation of more accurate significance estimates (p-
values) that will aid in the interpretation of a list of "top regulated genes," which are commonly
ranked by ratio alone.
Here we address the problem of accurately detecting genes that are significantly
differentially regulated between a pair of biological conditions, given microarray datasets with a
small number of replicates (e.g. N=3 arrays). If the number of replicates were very large (e.g.,
hundreds), the task would be relatively easy; since the ratio of expression levels between the two
conditions would be well estimated by the average ratio or median ratio, the genes could simply
be ranked by one of these estimates. In practice, however, the number of replicate arrays is
rarely greater than 3, and estimates of average expression ratios are not always sufficiently
accurate to predict which genes are truly regulated. The variation of a measured expression ratio
is critical in determining whether the observed ratio is due to random measurement fluctuations
or to a true difference between the quantities being measured. Genes with larger measured
expression ratios between conditions are more likely to be truly regulated, while genes whose
27
ratios have a high measured variance are less likely to be truly regulated. This idea can be
expressed mathematically as a test statistic where the numerator contains an estimate of the size
of the effect, i.e. the ratio of gene expression intensities between conditions, and the denominator
includes an estimate of the variance, i.e. the standard deviation of the ratio. A variety of such
statistical tests have been applied to microarray data (reviewed in [57, 69]); the challenge is to
choose the numerator and denominator of the test statistic such that it makes the best use of all
available data in order to get the most accurate determination of which genes are most likely to
be regulated.
3.1.2. Comparing Statistical Tests Used to Find Differentially Regulated Genes. The
familiar Student's t-test (hereafter, "standard t-test") is the most straightforward method of
calculating whether there is a significant difference in expression levels between conditions for
each gene. Suppose that mRNAs from two biological conditions, "X" and "Y", are hybridized to
a small number of replicate arrays (N two-color arrays or 2N one-color arrays). Mavg, the
average logged ratio of expression levels between conditions X and Y, and its sample standard
deviation, yoM, are given by the standard formulas (see Methods). A standard t-statistic is
M
calculated as t = .m/T From this formula, it is clear that a large t-statistic (and the
corresponding highly significant p-value) can occur because of either a large Mavg (high ratio) or
a small AM (low noise). Although the standard t-statistic (or derivates thereof based on
permutation [70] or Bayesian analysis [71]) can produce acceptable results for larger numbers of
replicates (e.g., N=8), the results are less than satisfactory when applied to a small number of
microarray replicates (e.g., N=3, Fig. 3.1). Fig. 3.1a shows data from an experiment that was
repeated 6 times on two-color arrays. The six arrays were split into two random groups of three
arrays, and the t-statistic described above was calculated for each gene in each group of three.
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Fig. 3.1. Evaluating the reproducibility oft-statistics between spots using a standard t-test. Two subsets of Dataset 4
each contain three replicate arrays derivedfrom identical biological experiments. (a) Comparison oft-statisticsfor each
subset. Values greater than 500 are not shown. (b) Comparison of average logged ratios Ma,,g, which is the numerator
of the t-statistic. (c) Comparison of the inverse of the standard deviation oM, which is in the denominator of the t-
statistic. Values greater than 150 are not shown.
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The t-statistics from the two groups are graphed against each other in Fig. 3. la. Although the
two groups contain replicate arrays from the same experimental conditions, the t-statistic is
clearly not reproducible between the groups. Fig. 3. lb and c demonstrate that Mavg, the
numerator of the t-statistic, is more reproducible between the two groups, while /oM,
representing the denominator of the t-statistic, is not reproducible. This example highlights the
major shortcoming of the t-statistic: due to random chance, the replicate ratios can occasionally
be extremely similar, producing an artificially low CM and high t values. False positives
stemming from this effect prevent the standard t-statistic from serving as a reliable or useful test
of which genes are truly regulated.
To overcome this limitation, various modifications to the t-statistic have been proposed.
First, a "penalized" t-statistic (also called a "moderated" or "regulated" t-statistic) can be used,
where a constant value is added to the denominator. Tusher et al. use a penalized t-statistic of the
form Ma 'g [72]. The addition of the constant so prevents the denominator from becomingf(UM +so)2 IN
small for low AM, reducing the false positive rate of genes with unusually low oM. Choosing too
large an so, however, effectively makes the denominator a constant, removing useful information
about the variability of genes. Estimating the optimal so for a particular dataset can be based on
minimizing the coefficient of variation of the absolute t-statistic values ("SAM") [72],
minimizing false positive and false negative estimates obtained through permutation ("SAMroc")
[69], or simply choosing so as the 9 0 th percentile of the AM values [73]. These studies have
demonstrated that when ranking genes from a microarray dataset, a penalized t-statistic can
perform better than a standard t-statistic in terms of decreasing the false positive and false
negative rate [57, 69, 71-74], but it also has the potential disadvantage of showing bias against
genes of high intensity [69].
30
An alternative to using a penalized t-statistic is obtaining a more precise estimate of the
standard deviation M. Such an estimate should be less susceptible to a chance concordance of
measurements of M that occasionally produces an extremely low oM and a high t-statistic. For
this purpose, knowledge of the relationships between the data points can be used to improve the
estimate. Namely, the variance values, or M2, for one spot can be pooled, or smoothed, with the
OM2 values of spots that are likely to have similar variances. The variance of microarray data has
often been observed to be a function of the spot intensity [65, 68, 74-83], raising the possibility
that the variances of individual spots can be pooled with those of spots of similar intensity to
produce a more precise estimate of the standard deviation. Several studies have taken into
account this intensity-dependent heteroscedasticity. For example, Rocke et al. [80] and Newton
et al. [66] have presented models of measurement error in microarrays that can explicitly take
into account higher variance at lower expression levels. More general approaches to variance
pooling have been implemented in a variety of ways, using loess-based curve fits [68], robust
nonparametric spline fits [81] and sliding windows for calculating either local averages [79, 82,
83] or interquartile ranges [77]. These more reliable estimates of the standard deviation can be
used directly to calculate Z-statistics, which are calculated according to the same formula as the
standard t-statistic, but correspond to lower p-values [79, 84].
3.1.3. Strategies for pooling standard deviations. The studies cited above use methods
that pool spots together based on their average intensity or logged intensity. For example,
consider one set of replicate spots with an average intensity of 128 (27) in one channel and 16384
(214) in the other channel compared to a set of replicate spots with an average intensity of 1024
(210) in one channel and 2048 (2' ) in the other channel (Fig. 3.2). Since both of these sets of
spots have the same average log2 intensity of 10.5, the standard deviations of their ratios would
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Fig. 3.2. Motivation for pooling standard deviations by minimum intensity. A hypothetical noise distribution is given with
higher noise at low intensities. Two sets of replicate spots (N=3 arrays) that have the same average intensity are shown.
However, example 1 produces a higher standard deviation of the logged ratio compared to example 2, because example 1
contains very low intensity measurements that fall into the noisiest range of the intensity scale. In this case, the minimum
intensity would differentiate between these two examples while the average intensity would not.
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be presumed to be similar and would be pooled together using the pooling methods described
above. However, these spots may actually be expected to have quite different standard
deviations; we have noted that many ratios with high variances result from spots that have a
medium or high intensity in one channel and a very low intensity in the other (data not shown).
Thus, the ratios for the first spot are expected to be more variable because of the very low
intensities (-100) in one channel. In this study, we test the hypothesis that if spots are pooled
together with other spots of similar minimum intensity over both channels (Iin), rather than
average intensity over both channels (Iavg), then a larger proportion of the high-variance spots
will be grouped together, resulting in a tighter fit of the pooled standard deviation curve to the
actual variance and generating more accurate estimates of the standard deviation.
This study expands upon previous work on intensity-dependent variance estimation for
microarray data by introducing a new metric, Iin, for pooling standard deviations. We evaluate
the performance of the Iavg and Iin metrics by explicitly comparing the reproducibility and
accuracy of the Z-statistics calculated using these two metrics. We also compare the
performance of the Z-statistics to the performance of other statistical techniques in current use,
the standard and penalized t-tests. Finally, we extend our technique for pooling standard
deviations to two-color microarray data from a reference sample experimental design.
3.2. Methods
3.2.1. Data Acquisition. The analyses in this study were performed on five different
datasets. Datasets 1-4 use the direct comparison experimental design, i.e. labeled cDNA from
two biological conditions, "X" and "Y," were co-hybridized onto a single array. Each dataset
was generated from a different biological experiment using two-color Agilent cDNA arrays. For
Datasets 1-3, microarrays were prepared essentially according to the manufacturer's instructions
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[85]. Briefly, 20 plg of total RNA were direct-labeled with Cy-3 and Cy-5, and labeled cDNAs
were hybridized overnight to Agilent Human 1 cDNA arrays (G4100a, Agilent Technologies,
Palo Alto, CA) containing 16,142 features representing approximately 10,500 unique genes.
After washing, the microarrays were scanned in an Agilent model G2505A microarray scanner.
Dataset 3 contains 3 replicate two-color arrays with condition X in the Cy-5 channel and
condition Y in the Cy-3 channel. Dataset 1 contains 3 replicates from another experiment,
including one dye-swapped array; i.e. condition X in the Cy-3 channel and condition Y in the
Cy-5 channel. Dataset 2 contains 3 replicate arrays without dye-swap, but each array was
hybridized with a different amount of RNA, 5, 10 or 20 gg.
Dataset 4 consists of 23 replicate Agilent cDNA arrays from the Alliance for Cellular
Signaling. The files MAE030201NOO.txt to MAE030223N00.txt were downloaded from
http://www.signaling-gateway.org/data/micro/cgi-bin/microcond.cgi. These arrays correspond to
the conditions "B-cell + SIMDM exposure=0 minutes" vs. "Spleen". Four additional arrays are
available for this condition (numbered MAE02070xNOO.txt), but these arrays appeared to be
slightly different from the other 23 arrays (using hierarchical clustering, data not shown) and
were excluded from further analysis. The B-cell RNA was derived from 23 preparations, each
from a different set of mice, while the spleen RNA was drawn from a single large pool (Rebecca
Hart, Alliance for Cellular Signaling at the California Institute of Technology, Pasadena, CA,
USA, personal communication).
Dataset 5 uses a reference sample design, where RNA from each experimental condition
is co-hybridized on an array with a standardized reference RNA sample. Dataset 5 contains three
replicates arrays for each experimental condition, for a total of 6 microarrays, generated in our
laboratory. Each of the arrays contains a reference RNA sample in the Cy-3 channel. Three
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have condition "X" samples in the Cy-5 channel and the other three have condition "Y" samples
in the Cy-5 channel. Since corresponding biological specimens for conditions X and Y were
prepared together for each replicate, a natural pairing exists for the condition X and Y arrays.
3.2.2. Computer Techniques. Statistical modules were programmed in Perl v5.8.
Microsoft Visual Basic 6.0 was used to integrate the image processing and statistical modules.
3.2.3. Image Processing. For Datasets 1-3 array images were processed using Agilent
Feature Extraction software version A.6. 1.1. The Feature Extraction Software provides
normalized Cy-3 and Cy-5 channel intensity values for each spot on an array (in the
gProcessedSignal and rProcessedSignal fields of the output files). The default settings were used
for all options. Quality control algorithms in the software detect unusual (poor quality) spots;
spots were excluded from analysis that contained a nonzero value any of the following fields:
IsSaturated, IsFeatNonUnifOL, IsBGNonUnifOL, IsFeatPopnOL, IsBGPopnOL, IsManualFlag.
For a detailed description of the Agilent Feature Extraction software and the algorithms it uses,
see the Agilent Feature Extraction Version 6.1 Users' Manual. Briefly, Agilent Feature
Extraction determines the foreground value for each channel based on the pixel values in a fixed-
size circle centered on each spot. The median of pixel values in a concentric ring around the
circle, with an excluded region between the outer boundary of the circle and the inner boundary
of the ring, gives the spot background value. The raw spot value is calculated as its foreground
value less its background value. A surrogate raw value is assigned when the foreground value
does not exceed the background value by two standard deviations of the spot's background pixel
values. Intensity-based normalization between channels using a linear regression and a lowess
curve-fit technique is then applied to remove any systematic dye incorporation biases.
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Images were also processed using SPOT (CSIRO, New South Wales, Australia)[86], an
R-based implementation which uses seeded region growing to determine the foreground pixels
for each spot and morphological opening to determine the background value for each spot. The
raw spot values, foreground less the background values, are normalized between channels using
an intensity-based Loess implementation in R available in the maNorm function of the
marrayNorm package of the open-source Bioconductor software (www.bioconductor.org). We
considered three image processing techniques: Agilent Feature Extraction output alone, SPOT
output alone with maNorm-based normalization and Agilent foreground (gMedianSignal and
rMedianSignal columns) less SPOT background (morphG and morphR columns) with maNorm-
based normalization.
3.2.4. Pooled Standard Deviations-Direct Comparison Design. Three replicate arrays
were processed for each direct comparison experiment. To map intensities from different
replicates onto similar scales without altering the absolute ratio values, we multiplied the
intensity values on each array by a constant such that mean square error between the intensities
of that array and the intensities of the first replicate array was minimized. The multiplicative
G
' (XlgXjg +ylg yg )
factor for array j is given by g=' , where G is the total number of spots and x and y are
E (xjg2+y, 2)
g=i
intensities for condition X and condition Y. Then, for each spot, the mean and sample
(measured) standard deviation (a) across array replicates were calculated for the logged ratio M
= X-Y, where X and Y are log2(x) and log2(y). The sample standard deviation of M, aM, is
(Mi-M, ") 
calculated as m=1 .N- A replicate spot for which either channel was flagged as poor
quality was excluded from these calculations. Spots for which there were less than two
replicates of good quality were discarded from analysis.
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The pooled logged ratio standard deviation, Y'M, was calculated by sorting all the spots by
the average logged intensity Ivg = Xv +Yg or the minimum logged intensity In across both
channels of all replicates and then taking the square root of the moving average of the variance
cM2 with a window of 501 spots. We averaged the variance instead of the standard deviation,
since averaging the standard deviation directly will produce a negatively biased (-13%) estimate
for N=3 [87]. The Z-statistic was then calculated as -g Note that Iavg and M as defined
above are equivalent to the symbols A and M, respectively, as used in other studies [70]. The
common "M-A plot" would be called an "M-I plot" using the notation of this study.
3.2.5. Pooled Standard Deviations-Reference Sample Design. Three pairs of arrays
were processed for each reference sample experiment. For the unpaired analysis, the arrays
within a given condition were linearly normalized to each other, in order to map intensities from
different replicates onto similar scales without altering the absolute ratio values (as described
above). For each condition, the mean Mavg and sample standard deviation oM of the logged ratio
were calculated for each feature. The pooled standard deviation of the logged ratio, C'M, was
calculated by sorting all the spots by the average intensity, Iavg, or the minimum intensity, Imin,
across both channels of all replicates for the condition and then taking the square root of the
moving average of the variance oM2, with a window of 501 spots, centered on the given spot.
M -MThe Z-statistic was calculated as M a,gM Ya'- where Nx and N¥ are the number of replicates
.MX INX +My /NY
for the given spot for condition X and condition Y, respectively.
For the paired reference sample analysis, the intensity vectors were all linearly
normalized to the vector for the first replicate array of condition X to put all intensity values
from both conditions on the same scale without changing the value of the ratios. Then the paired
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difference of logged ratios g = Mx- My for each pair of replicates was computed. The mean and
sample standard deviation of t was then calculated across replicates. The pooled standard
deviation of pg, o',, was calculated by sorting all the spots by the average intensity Iavg or the
minimum intensity Inin across both channels of all replicates for both conditions, and then taking
the square root of the moving average of the variance o42, with a window of 501 spots. The Z-
statistic was calculated as where N is the number of paired replicates for the spot.
To compare Z-statistic values between the paired and unpaired methods, the linear
regression slope coefficient with intercept set to 0 was calculated between corresponding Z-
statistics from the two methods.
3.2.6. Calculation of p-values. For a Z-statistic Z, the two-tailed p-value is given by 1-
2F(IZI), where D is the cumulative distribution function for the zero-mean, unit-variance
Gaussian. The p-value is corrected for multiple tests using Sidak's formula, p' = 1-(l-p)L, where
L is the total number of spots being examined. Note that we did not find it necessary to use more
sophisticated means of controlling the error rate [70, 88], as we are primarily concerned with
ranking regulated genes and not in establishing firm statistical cutoffs.
3.2.7. Calculation of standard t-statistics and penalized t-statistics. Standard t-statistics
for direct comparison arrays were calculated with the formula t = '' . The two-tailed p-
value was calculated using a t distribution with N-1 degrees of freedom. In a penalty-based
technique, a constant penalty so is included in the denominator of the t-statistic. The new
statistic, d, is given by v/Mag . Two different methods of choosing so were used: setting so
to equal the 90th percentile of the actual standard deviations and the significance analysis of
microarrays (SAM) technique, which chooses s such that the coefficient of variation of d is
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minimized. The SAM technique was implemented using software developed at Stanford
University Labs [72, 82]. This software imputes missing logged ratio values before calculating
so, and this feature cannot be disabled. The K-nearest-neighbor technique was selected for
imputation.
3.2.8. Outlier Detection. When outlier detection was enabled, Z-statistics were calculated
using the measured standard deviation instead of the pooled standard deviation for outlier spots.
Outliers were determined by calculating oE, the standard deviation of the residual error E = - '
for spots with c > '. Spots for which E > 2oc were treated as outliers, similar to [79]. The
measured standard deviations for the outlier points were considered to be valid sample
measurements of the variance process and were not excluded from the calculation of the pooled
standard deviations for spots with similar intensities.
3.2.9. Comparison of Z-statistic and penalty-based statistics. In order to test the
reproducibility of different test statistics (cf. Fig. 3.6), two sets of three arrays were randomly
selected from the 23 replicate arrays in Dataset 4. For both of these subsets, we calculated the
several different test statistics described above. For each gene, the value of each of the test
statistics from one 3-array subset was compared to the corresponding value from the other
subset, using the squared Pearson's linear correlation coefficient, R2, and two non-parametric,
rank-based correlation coefficients, Spearman Rho and Kendall Tau, which were calculated
using JMP (SAS Inc., Cary, NC). This entire process was repeated twice with the remaining
arrays in Dataset 4, yielding a total of three independent comparisons. In total, six non-
overlapping sets of three arrays-18 arrays in all-were drawn from the original pool of 23
arrays, leaving 5 arrays that were not used in this analysis. As the sets are non-overlapping, each
comparison is based on independent data.
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In order to evaluate the accuracy of the different test statistics, we compared these
statistics to an approximate "gold standard" measure (cf. Fig. 3.5). 3 arrays were randomly
selected from the 23 arrays in Dataset 4; the other 20 were used to calculate "gold standard" t-
statistics to which the results from the n=3 dataset could be compared. The R2 value and the
linear regression slope coefficient with intercept set to 0 were calculated between the
corresponding experimental statistic and "gold standard" t-statistic for each gene. Only spots for
which there were at least 15 replicates in the "gold standard" set of arrays were used. This
process was repeated on a total of 6 random subsets.
3.3. Results
3.3.1. Average Logged Intensity (Iavg) vs. Minimum Logged Intensity (Imin) Pooling
Metric. We demonstrate our technique of pooling standard deviations using the three arrays in
Dataset 1 as a representative example of a "direct comparison" dataset. For each spot, we
calculate the average logged ratio Mavg and the standard deviation of the logged ratio oM, across
the three replicates. The spots are then sorted by either average intensity (Iavg) or minimum
logged intensity (Imin) before pooling. Fig. 3.3a and b show the results of pooling standard
deviations for Dataset 1, using either the Iavg or Imin metrics; the measured standard deviation OM
and the pooled standard deviation AM' are plotted together against either Iavg or Imin. For better
comparison, the pooled standard deviation curves for G(M'(Iavg) and M'(Imin) are both plotted
together on Fig. 3.3c against their respective intensity metric, Iavg or Imi. Fig. 3.3 is based on
data produced using the Agilent Feature Extraction software Version A.6.1.1 to quantify spot
intensities in the original microarray image. This entire analysis was repeated on Datasets 2 and
3, as well as using two additional image processing techniques: SPOT Processing [86] and a
combination of Agilent foreground and SPOT background values (see Methods).
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Fig. 3.3. Two methods ofpooling standard deviations of M. sorting by Iavg or by Imi,,
.
The standard deviation (M) is
pooled by taking the moving average of the variance (aM2). (a) Measured (aM, gray) and pooled (M'(Iavg), black)
standard deviation of the logged ratio M, plotted against Iavg. For spots with 7M' > aSM, the average residual error is
0.28, for spots with CM' < 'M, the average residual error is 0.31. (b) Measured (oM, gray) and pooled (M'(IJi,,), black)
standard deviation of M, plotted against Im,,
.
For spots with M
' > o'M, the average residual error is 0.28,; for spots with
c, ' < o x , the aver-age residual error is 0.31. (c) Pooled standard deviation of M (7M') plotted against the intensity metric
used for pooling, I'vg or Imi,,. Data are from Dataset 3.
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Fig. 3.4. Comparison ofpooled standard deviation curves using Iavg or Im, pooling
metrics. The pooling algorithms are applied to a noisy three-array subset of Dataset 4.
(a) Measured ( M, gray) and pooled (M'(Iavg) black) standard deviation of M, plotted
against Ivg For spots with M
'
> M, the average residual error is 0. 45; for spots with
TM' < M, the average residual error is 0.49. (b) Measured (M, gray) and pooled(qM'(I,,), black) standard deviation of M, plotted against Imi,
.
For spots with CM ' > oM',
the average residual error is 0.24, for spots with o7M ' < M, the average residual error is
0.23.
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'7rC__
Dataset 1
Dataset 2
Dataset 3
Dataset 4 #1
Dataset 4 #2
Dataset 4 #3
Dataset 4 #4
Dataset 4 #5
Dataset 4 #6
SPOT Processina
GM2 ' > M2
lavg
0.28
0.24
0.20
0.15
0.20
0.45
0.21
0.25
0.18
Iminm
0.28
0.23
0.18
0.14
0.17
0.24
0.20
0.19
0.17
GM
2
< M
2
lavg
0.31
0.25
0.21
0.17
0.23
0.49
0.23
0.28
0.21
Imin
0.31
0.25
0.18
0.15
0.19
0.23
0.21
0.20
0.18
GM2 > M2
lavg
0.19
0.15
0.09
NA
NA
NA
NA
NA
NA
0.20
0.15
0.09
NA
NA
NA
NA
NA
NA
GaM
2
< M
2
lavg
0.22
0.16
0.09
NA
NA
NA
NA
NA
NA
Imin
0.25
0.17
0.09
NA
NA
NA
NA
NA
NA
GM
2
> M
2
lavg
0.19
0.15
0.09
NA
NA
NA
NA
NA
NA
Imin
0.20
0.15
0.09
NA
NA
NA
NA
NA
NA
CTM < (M 2
lavg
0.22
0.16
0.09
NA
NA
NA
NA
NA
NA
Imin
0.25
0.17
0.09
NA
NA
NA
NA
NA
NA
Table 3.1. Mean residual errors for spots with ATM'> AM and AM'< icM, using ,,vg or Imi, pooling metric. Data is given
for three datasets using different image processing techniques (Agilent Feature Extraction, SPOT Image Processing
and Agilent foreground combined with SPOT background), and for 6 independent three-array subsets of Dataset 4.
We evaluated the tightness of the Iavg-pooled vs. Im,,-pooled standard deviation curve fits
to the measured standard deviations. Figs. 3.4a and b plot both measured (G(M) and pooled (M')
standard deviations against either the Iavg or Imin pooling metric, analogous to Fig. 3.3a and b but
using an especially noisy three-array subset of Dataset 4 that includes a population of extremely
high variance spots. Instead of pooling together spots with similar variance, the Iavg metric
combines the high-variance spots with the lower-variance spots. In contrast, the Imin metric
pushes the high-variance spots to the left end of the curve, apart from the less noisy spots. This
effect is reflected in the lower mean residual errors between oM and GM' for the Imin metric,
calculated for Datasets 1-3 and six independent three-array subsets of Dataset 4 (see Table 3.1).
For all of the datasets processed with Agilent Feature Extraction software only, the mean
residual errors from using the Imin pooling metric are always less than or equal to the
corresponding mean residual errors from using the Iavg pooling metric. This observation is most
striking for Dataset 4 subset #3, which corresponds to the data in Fig. 3.4. The tighter fit that is
obtained using the Imn, metric is also reflected in the improved accuracy of the final Z statistic
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Fig. 3.5. Comparing the accuracy of different test statistics. Statistics were calculated for 3 replicate arrays
from Dataset 4 and compared to the "gold standard" t-statistic for the remaining 20 arrays. The x-axis for all
plots is the "gold standard" t-statistic. The y-axis shows: (a) average logged ratio Mavg, (b) standard t-statistic,
(c) 9 0 th percentile penalized t-statistic, (d) SAM penalized t-statistic, (e) Z-statistic using the Iavg pooling metric,
or (f) Z-statistic using the I,n j pooling metric.
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calculated using OM'(Imin), which is demonstrated in Fig. 3.5 and discussed below. The trend in
residual values is not present when datasets are processed with the SPOT technique or with
Agilent foreground and SPOT background.
3.3.2. Comparing the Accuracy of Different Ranking Statistics. In order to test the
accuracy of the different test statistics-Mavg, the standard t-statistic, the 90th percentile
penalized t-statistic, the SAM penalized t-statistic, Z(Iavg) and Z(Imin)-a subset of three arrays
was randomly selected from the total set of 23 replicate arrays in Dataset 4 (see Methods). Each
statistic was calculated for each gene in this set. The large number of remaining replicate arrays
allowed us to calculate an approximate "gold standard" statistic, tgold, by computing the standard
t-statistic over the set of 20 remaining replicates. The value of each test statistic from the three-
array subset was compared to the value of the "gold standard" t-statistic, tgold, as shown in Fig.
3.5. The squared Pearson's linear correlation coefficient value (R2), representing the degree of
concordance between the test statistic and tgold, was calculated. This analysis was repeated five
additional times, selecting different subsets of experimental and "gold standard" arrays from
Dataset 4 each time, and the R2 values from all six repetitions are given in Table 3.2. The Z-
statistics and penalized t-statistics both have appreciably higher R2 values than either Mavg or the
standard t-statistic. The R2 values for Z(Imin) are greater than the R2 value for any other
technique across all six datasets. Note that there is less scatter for high-magnitude values when
using Z(Imin) instead of Z(Iavg) (Fig. 3.5e and f respectively). Accordingly, the R2 value is higher
for the Z(Imn) than the Z(Iavg) ranking metric for all three datasets, confirming that the tighter
curve fits seen in Fig. 3.4a and b and Table 3.1 (see above) translate into improved accuracy of
using the Imin pooling metric over Iavg.
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Dataset 4 #1
Dataset 4 #2
Dataset 4 #3
Dataset 4 #4
Dataset 4 #5
Dataset 4 #6
0.69
0.66
0.54
0.68
0.64
0.67
0.09
0.08
0.04
0.02
0.06
0.01
0.80
0.78
0.79
0.80
0.80
0.80
0.80
0.78
0.70
0.79
0.74
0.80
0.79
0.79
0.77
0.80
0.78
0.79
0.83
0.82
0.84
0.83
0.84
0.83
Table 3.2. Accuracy of each test statistic when compared to a "gold standard" t-statistic. Each column contains
the R2 value calculated between each experimental test statistic and the "gold standard" t-statistic for (left to right):
the average logged ratio M,,vg, the standard t-statistic, the 9Qh percentile penalized t-statistic, the SAM penalized t-
statistic, the Z-statistic using the ,,vg pooling metric and the Z-statistic using the Imin pooling metric. Data are from
six independent three-array subsets of Dataset 4. Although Mvg is not a statistical test, it is included in this Table
3.for comparison.
3.3.3. Comparing the Reproducibility of Different Ranking Statistics. We also evaluated
the reproducibility of these different test statistics, by constructing test datasets that split six
replicate arrays from Dataset 4 into two subsets of 3 arrays (see Methods). Each test statistic-
Mavg, the standard t-statistic, the 90th percentile penalized t-statistic, the SAM penalized t-
statistic, Z(Iavg) and Z(Imin)- was calculated for both three-array subsets. A precise, i.e.,
reproducible, test statistic should produce similar values for both subsets since all of the arrays in
both subsets were drawn from a pool of replicates prepared from identical biological
experiments. Fig. 3.1 a-b and Fig. 3.6a-d show the correlation for each test statistic between the
two subsets, including a linear regression line in Fig. 3.6. The slope coefficient of the linear
regression indicates whether overall magnitudes of the test statistics are different between the
two subsets, while R2 indicates the degree of correlation on a gene-by-gene basis (Table 3.3).
This analysis was repeated for an additional two pairs of independent three-array subsets of
Dataset 4 (graphs not shown), with the slope coefficients and R2 values given in Table 3.3.
The R2 values for the two Z-statistics were similar to each other and consistently higher
than those of the other techniques. Nonparametric measures of correlation, the Spearman Rho
46
M.... t dRAM1 Z(LI.) Z(Im,-)
(a) (b)
I
8
'0Z4
P)
ID
d9oth percentile_1 dSAM_I
(c) (d)
N pt225-
-50 l
Z(lavg)_i Z(Imin)_
Fig. 3.6. Comparing the reproducibility of different test statistics. Two subsets of Dataset 4 each contain three replicate
arrays derivedfrom identical biological experiments. Each test statistic is calculated twice, once for each subset, and the
two statistics are plotted against each other. (a) Comparison of 90t1 percentile penalized statistics. (b) Comparison of
SAM penalized statistics. (c) Comparison of Z-statistics using Iavg pooling metric. (d) Comparison of Z-statistics using
I,, pooling metric. Also see Fig. la for comparison of the standard t-test.
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and Kendall Tau rank correlation coefficients, were also higher for both Z-statistics than any of
the other statistics for all three pairs of subsets (data not shown). All three calculations of the
slope coefficients for both Z-statistics, as well as Mavg and the 9 0 th percentile penalized t-statistic,
are close to 1, indicating that the overall magnitudes of the Z-statistics are consistent across
datasets, whereas the standard t-statistic and the SAM penalized t-statistic produced test statistics
whose overall magnitudes vary across the subsets.
Dataset 4 #1
I Dataset 4 #2
Dataset 4 #3
Dataset 4 #1
. Dataset 4 #2
Dataset 4 #3
0.89
0.90
0.89
0.90
0.93
1.00
0.00
0.00
0.00
0.00
0.01
0.07
0.86
0.87
0.88
0.97
0.96
0.96
0.87
0.87
0.88
1.63
0.58
0.74
0.93
0.93
0.95
1.00
1.02
1.09
0.94
0.93
0.95
1.00
1.04
1.08
Table 3.3. Reproducibility of each test statistic when used on replicate datasets. Linear regression slope
coefficients and R2 coefficients are calculated between corresponding statistics from two replicate three-array
subsets of Dataset 4. Columns represent (left to right): the average logged ratio Mavg, the t-statistic, the 9 0 th
percentile penalized statistic, the SAM penalized statistic, the Z-statistic using I,,v pooling metric and the Z-statistic
using Imi for three different pairs of subsets. Although M,,vg is not a statistical test, it is included in this Table 3.for
comparison.
3.3.4. Outlier Detection. When calculating the Z-statistic, using a much smaller pooled
cM' in place of a large caM has the potential to overestimate the significance of gene regulation in
the case where one of the replicates is an outlier measurement and the large measured standard
deviation provides a better estimate of the variability. As seen in Fig. 3.3a-c, there are several
spots that lie far above the pooled standard deviation curve. Datasets 1 and 4 were reprocessed
using an outlier detection technique (see Methods). Fig. 3.7a shows oM and (M' from Dataset 1
plotted against Imin, as in Fig. 3.3c, except that the y-axis has been rescaled to show all spots
detected as outliers, which are now highlighted in black.
The accuracy of this outlier detection technique was also evaluated by comparing the Z-
statistic to tgold using Dataset 4. Fig. 3.7c plots Z(Imin) vs. tgold for Dataset 4 set #2. The outliers,
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Fig. 3.7. Implementation of outlier (high experimental standard deviation) detection. (a) Measured (M, gray) and
pooled (rM'(Ii,,), black curve) standard deviation of M, plotted against Imi,,, with the outlier spots highlighted (black
points), for Dataset 3. (Compare to Fig. 3.3b.) (b) Scatterplot of average condition X intensity vs. average condition Y
intensity for Dataset 3, with p-values indicated in color. (c) Z-statistic using I i, pooling metric vs. "gold standard " t-
statistic with outliers highlighted in black, for a 3-array subset and 20-array "gold-standard" subset of Dataset 4.
Outlier Z-statistics calculated using the pooled standard deviation. (d) Z-statistic using Imj,, pooling metric vs. "gold
standard " t-statistic, with outliers highlighted in black, for the same data in (c). Outlier Z-statistics calculated using the
measured standard deviation, for Dataset 4 subset #2.
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which are highlighted, include false positive spots for which tgold is low and Z(Inin) is high,
although not all such points are detected as outliers. Fig. 3.7d is an identical plot to Fig. 3.7c
except that the Z-statistics for the outlier spots are calculated using the higher-valued measured
standard deviation icM instead of the pooled value AM'. The outliers are now mostly clustered
around the origin with the other non-significant spots. A few spots with moderately high tgold
values are detected as outliers and have low corrected Z-statistics, and some potential false
positives with high Z-statistic values and low tgold values are not detected as outliers.
At the end of the analysis, the outlier-corrected Z statistics are converted to p-
values. To demonstrate the additional information that the p-values provide, Fig. 3.7b shows a
scatterplot of X vs. Y for Dataset 1, with statistically significant spots colored according to their
multiple-test-corrected p-values (see Methods). Spots with similar ratios may have different p-
values due to their different standard deviations. In addition, after outlier detection, some spots
with high ratios are not found to be significant.
3.3.5. Analysis of Reference Sample Arrays. The techniques used above for a direct
comparison experimental design were extended to a reference sample design (see Methods).
Under a reference sample design, one can estimate either the standard deviation of the individual
logged ratios comparing experimental samples to the reference sample, Mx and My, or the
standard deviation of the paired differences of these logged ratios, p. = Mx-My. Under the first,
or unpaired method, the Z-statistic is calculated as aMg ag" where Nx and Ny are the
V"Mx I Nx + My I Ny
number of replicates for the given spot for condition X and condition Y, respectively. Under the
second, or paired method, the Z-statistic is calculated as where N is the number of paired
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Fig. 3.8. Methods ofpooling the standard deviation for a reference sample design. The standard deviation (a) is pooled
by taking the moving average of the variance(o;). (a) Measured (o,,, gray) and pooled (%,' (Imi), black) standard
deviation of the difference of logged ratios A plotted against Imn,. (b) Pooled standard deviation of Mx, My and u plotted
against the intensity metric used for pooling, Iavg or Ii,l. Data are from Dataset 5.
51
I_~t----· I
'aE
replicates for the spot. The samples used in a reference sample design may not always have been
collected or processed in pairs, so we evaluated both of these methods.
For each replicate in reference sample Dataset 5, the biological specimens for conditions
X and Y were prepared on the same day, so a natural pairing exists for the condition X and Y
arrays. These data were processed using all three image processing techniques and then
analyzed using both paired and unpaired methods, and using either the Iavg or Imin pooling metric
for each approach. Fig. 3.8a shows the measured and pooled standard deviation of the paired
differences of logged ratios (o and o,') plotted together against the pooling metric, Iin. Curve
fits were analogously constructed using the Iavg pooling metric with the paired method (with
results similar to using the Imin metric, data not shown), and using both Iavg and Imin with the
unpaired method (with results similar to using the ratio method with direct comparison arrays,
data not shown). The unpaired aM' and paired ao' curves are plotted together against their the Iavg
or Imin pooling metric in Fig. 3.8b. The paired standard deviations are lower than the unpaired
standard deviations except at low intensity metric values.
Linear regression was performed between Z-statistics calculated using the paired and
unpaired methods for all spots. Table 3.4 gives the linear regression slope coefficients when
either the Iavg or Imin pooling metric was used, for Dataset 5 processed with the three different
image processing techniques. For most spots, both the difference of logged ratios () and
number of replicates (N) are the same, except for the occasional difference between the two
conditions in the number of low quality spots that are excluded from the analysis. Thus,
differences in the Z-statistic primarily reflect differences in the standard deviations. The slope
coefficients are all greater than 1, indicating that the paired technique produced higher Z-statistic
values, due to the lower standard deviations that are produced with paired analysis.
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Agilent Feature SPOT Agilent FG +
Extraction SPOT BG
lavg 1.70 1.68 1.70
min 1.59 1.61 1.63
Table 3.4. Linear regression slope coefficients calculated between the corresponding Z-statistics using independent
or pairwise analysis. Coefficients given for reference sample design Dataset 5. Values greater than I indicate
higher Z-statistics with the pairwise technique. Data is shown for both pooling metrics lavg and lmi and for three
different image processing techniques. Every linear regression analysis produced an R2 value greater than 0.89
(data not shown).
The mean residual errors for spots with a' < a and a' > a were calculated when using the
Iavg or Imin pooling metric in unpaired or paired analyses of Dataset 5, and are given in Table 3.5.
For the unpaired analysis, as in the direct comparison experiments, mean residual values
produced by using the Imin pooling metric are less than or equal to those produced by the Iavg
pooling metric. The same trend is seen between the two pooling metrics for the paired analysis.
These results are consistent regardless of the image processing technique used.
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lavg
0.19
0.22
0.19
Imin
0.18
0.18
0.18
(,21< 2
.-. a
Iava
0.21
0.25
0.22
Imin
0.20
0.23
0.19
(2, > (2
0.14
0.16
0.13
Imin
0.14
0.14
0.13
,g2' < 2a a2
Iava
0.15
0.17
0.14
Imin
0.15
0.17
0.14
2, > (2
I.ava
0.13
0.15
0.12
Imin
0.13
0.13
0.12
OruLI ou
o2 < 2
Iava
0.14
0.16
0.12
0.14
0.16
0.12
Table 3.5. Mean residual errors for spots with 2'> a2 and o2'< C2 , using ,,vg or Imin pooling metric. Analysis was
performed on Dataset 5 (reference sample design). Data is given for both unpaired and paired analyses, using
three different image processing techniques: Agilent Feature Extraction, SPOT Image Processing, and Agilent
foreground combined with SPOT background.
3.4. Evaluation of Algorithm Performance
Building up new knowledge about biological systems is the ultimate purpose of
microarray experiments, but all such insights have to be built on a solid analytical foundation to
be accurate and useful. Proper normalization of data and accurate detection of which genes are
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regulated are vital to the success of downstream exploration of microarray data. Even for
exploratory cluster analyses, the genes that are significantly regulated must be selected
beforehand. This task of detecting these genes is a difficult statistical problem; a statistical
hypothesis is made for each of tens of thousands of genes tested, but only a small number of
replicate arrays are available to test those hypotheses. The statistical methods presented in this
study attempt to draw as much information as possible out of a small number of array replicates
to determine which genes are likely to be regulated.
It is clear that looking at the measurements of each gene in isolation can produce a test
with low statistical power (e.g. using the standard t-test, Fig. 3.1). To improve statistical power,
we can use knowledge about the relationships among the many thousands of points in the arrays.
Specifically, we group together spots that have similar standard deviations and then pool together
many less accurate estimates of standard deviation into a single, more accurate estimate. Our
data also show that the Z-statistics are more precise than either standard or penalized t-statistics
for detecting differential gene expression in microarray data. We further demonstrate that
pooling standard deviations using the minimum intensity metric produces Z-statistics that are
more accurate than the standard t-test, the penalized t-tests, and the average intensity-based Z-
statistic.
3.4.1. Average Combined Logged Intensity (I_) vs. Minimum Logged Intensity (Imi
Pooling Metric. We evaluated two different intensity-based metrics for pooling standard
deviations. There are many reports that the variance is a function of intensity, but the exact
shape of this relationship could depend on many factors extrinsic to the biological experiment,
such as the array technology being used, the signal-to-noise ratio of the data, the similarity
between the two conditions[83], the normalization technique or the background subtraction
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technique. For this reason, we favor an estimation of the standard deviation using a curve-fitting
technique rather than a fixed model based on previous data. Furthermore, when dealing with
two-channel arrays, there are two different intensity values associated with each replicated spot.
It is possible that the variation is best described as a function of the average intensities of both
channels. However, our own experience and many other reports [74, 78, 89] suggest that the
highest variances are often seen for low intensity spots. If so, the variance may be better
described as a function of the minimum intensity over all the spots.
The data presented here show that the mean residual errors are either equal or lower when
using the Imin compared to the Iavg pooling metric, for every dataset using the Agilent Feature
Extraction image processing technique. The subset of Dataset 4 for which this difference is most
striking, #3 in Table 3.1, also has a population of spots with particularly high variance (see Fig.
3.4). The Iavg metric pools these spots together with other spots that have a much lower variance.
In contrast, the Imin metric moves these spots to the low end of the x-axis, and the curve fit tracks
the standard deviation of the spots much better. The noisiest spots on microarrays are often
those where at least one channel is "blank", i.e. a noisy, low level of signal that presumably
represents no expression. The Imi, metric is better at grouping such spots together. For datasets
with low background levels, there is a smaller difference in the performance of the two pooling
metrics.
The trends in the mean residual errors from the unpaired reference sample analysis agree
with the results from the direct comparison analyses. This similarity is to be expected, since
processing each reference sample condition separately is equivalent to doing a direct comparison
between each condition and reference RNA samples. Both pooling metrics generate similar
mean residual error values when pooling ca,, but one dataset is not enough to make any
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generalizations about which pooling metric will perform best for all paired reference sample
datasets. The improved performance of the Imin pooling metric is lost when using SPOT
processing or combined Agilent foreground and SPOT background image processing, suggesting
that these image processing techniques may be more effective at removing noise at low
intensities.
The Iavg and Imjn pooling techniques are reproducible to the same degree, since their R2
coefficients between Z-statistics from paired datasets (see Table 3.1) are similar to each other.
The Imin pooling technique generates slightly more accurate results, as indicated by the greater R2
coefficients between Z(Imin) and tgold compared to those between Z(Iavg) and tgold (see Table 3.2).
This trend holds for all six subsets of Dataset 4.
3.4.2. The Higher Accuracy of Z(I& The Z-statistic calculated using the Imin pooling
metric provides an improvement in accuracy over the other techniques. The t-statistic derived
from datasets with 20 replicates was used as a surrogate "gold standard" since 8 or more
replicates can be considered sufficient to give power to the t-statistic [70]. The t-statistic was
chosen as the "gold standard" instead of the average logged ratio since the latter does not take
variability into account. For each of the six permuted subsets of Datasets 4, the 9 0 th percentile
penalized t-statistic, SAM penalized t-statistic, and Z(Iavg) had similar R2 values when correlated
with the "gold standard" t-statistic, although the SAM statistic did perform poorly for the noisiest
subset of Dataset 4 (#3 in Table 3.2) with an R2 value of only 0.70. Z(Imin), however,
consistently produced the highest R2 value for each of the six datasets. Since the ratios used in
each of these statistics is identical, this result indicates that the standard error generated with the
Imin technique produces the best correlation with the gold standard t-statistic based on 20
replicates. Although excluding spots with very low intensity could eliminate the difference in
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performance between the Imni and Iavg pooling metrics, this approach would make it impossible to
detect low-expressed regulated genes, which may be biologically significant.
The Z-statistics from the Imin technique do not correlate perfectly with the "gold standard"
t-statistic, however. Some disagreement can be expected because the Z(Imin) data was based on
only three replicate arrays, which contain much less information than the 20 replicates used to
calculate the "gold standard" t-statistic. Also the significance estimates calculated using the
"gold standard" t-statistic may still contain some inaccuracies, even with 20 replicates. Kerr et
al. found this to be true with 12 replicates, where accuracy is reduced if the error distribution for
each gene is modeled separately instead of using a pooled estimate [68]. Analyzing the large
(N=20) replicate dataset using robust estimators of ratio and standard deviation may be able to
create a more accurate "gold standard" to use for further testing of the Z-statistic or other
statistics. Note that we do not employ an explicit permutation-based approach to estimate the
false detection rates of the statistics investigated in this study, as in Ref. [69]. Rather than
permute gene labels from a small set of arrays to estimate the distribution of expected test
statistics, with the availability of the large (N=23) replicate dataset described herein, we
preferred to use this rich source of actual test statistics directly.
3.4.3. The Higher Reproducibility of Z-statistics. The Z-statistic--calculated with either
pooling the Imin or Iavg pooling metric-provides an appreciable improvement in reproducibility
over the average logged ratio alone, the standard t-test and the 90 th percentile and SAM
penalized t-statistics. Both linear (R2) and non-parametric rank correlation coefficients were
highest for the Z-statistic when comparing corresponding spots between three independent pairs
of replicate datasets. Also, the standard t-statistic and SAM penalized t-statistic generate linear
regression slope coefficients that vary greatly from pair to pair, indicating that their absolute
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magnitude is not as reproducible as the Z-statistics, whose linear regression slope coefficients are
much closer to 1.
The high correlation values and near-unity slope coefficients for the Z-statistic support
the hypothesis that pooling the standard deviations of spots with similar intensities provides a
stable, precise estimate of the standard deviation. This assumption of a well-estimated standard
deviation supports the use of the Gaussian distribution to map the Z-statistic to a p-value. Using
only the measured standard deviation, one is forced to use a t-distribution with only 2 degrees of
freedom to generate a p-value. This test does not have sufficient power to generate any
significantly regulated points; because of the very small number of degrees of freedom, not a
single spot seen in Fig. 3.la is found to be significant after multiple test correction. In contrast,
even after a conservative multiple test correction that makes the cutoff for statistical significance
much more stringent, many spots are found significant using the Z-statistic. The penalized t-
statistics do not produce a stable estimate of the standard deviation with these data, perhaps
because the constant added to the denominator of the test statistic showed a large variation
between replicate datasets. Therefore they cannot be mapped to a p-value in a reproducible
manner.
3.4.4. Outlier Detection. One limitation of using a pooled standard deviation is that for a
spot with replicate ratios that include one or more outliers, the appropriately high measured
standard deviation will be replaced by an inappropriately low pooled standard deviation. This
substitution could produce a false positive result. We have sought to minimize this limitation by
implementing an overlying outlier detection algorithm. (For other implementations of outlier
detection, see Ref. [79, 83].) The algorithm in this study uses the measured standard deviation
instead of the pooled standard deviation for spots for which the pooling model may not hold.
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These spots are identified as ones for which residual error o-aY' is positive and greater than twice
the standard deviation of the positive residual errors.
The measured standard deviations for these outlier points are valid sample measurements
of the variance process and should be used to calculate the pooled standard deviations for spots
with similar intensities. These ratio measurements, however, are too widely varying for one to
have the same confidence in the average ratio as one would have for other spots; thus, it is
appropriate to substitute the measured standard deviation for the pooled standard deviation in
these cases. Fig. 3.7c-d, which highlight outlier spots on a plot of the Z(Imin) vs. the "gold
standard" t-statistic for Dataset 4b, show that this outlier detection technique correctly detects
many of the presumably false positive spots that have a high Z-statistic and low tgold value. The
plots also show some false positive spots that are not detected through this algorithm, as well as a
few spots that become false negatives after outlier detection. Other, more complex outlier
detection algorithms may perform better, and should be explored. A simple modification to the
current algorithm, using local instead of global estimates of the standard deviation of the residual
error, may improve outlier detection. Alternative implementations include modifying the
pooling window shape to give more weight to a spot's measured standard deviation or that of its
nearest neighbors by intensity. Strictly speaking, the p-values for outlier spots should be
calculated using a t-distribution instead of a Gaussian distribution since the measured standard
deviation is being used. We have shown, however, that with 3 replicates, no spots in our datasets
can be found statistically significant using the t-test and strict multiple test correction. In order
to preserve detection of spots, we continue to use the Gaussian distribution to convert outlier Z-
statistics to p-values, which may slightly increase the false positive rate for spots detected as
outliers. In practice, however, such spots are rarely found to be significantly regulated.
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3.4.5. Unpaired vs. Paired Analysis for Reference Sample Experiments. Finally, we have
extended our algorithms to apply to data from a reference sample experimental design. This
design gives one the flexibility to compare many different conditions to one another, but the
trade-off is a loss in precision. In theory, using a reference sample design instead of a direct
comparison design should increase the variance by a factor of 2. This increase has in fact been
observed in practice [90].
The paired analysis method can reduce the measured variation in a reference sample
design. The linear regression slope coefficients in Table 3.1 indicate that the Z-statistic values
using the paired analysis are higher than the unpaired Z-statistic values. Thus, the paired
difference of logged ratios, , is less variable than the independent logged ratios, Mx and My.
This observation suggests that the effects of biological or analytical variation from replicate to
replicate can be reduced if comparisons are made between paired samples. Whether this
reduction is due to using paired biological samples or paired array processing dates [91] is still
an open question, and probably will be context-dependent. Although it may not always be
practical, it would be beneficial for investigators to design reference sample experiments to be
performed in parallel whenever possible to take advantage of the lower standard deviations
produced by paired analysis.
3.4.6. Finding the optimal statistical test. Several areas remain for further refinement of
our implementation of pooling-based statistical analysis of microarray data. Currently, the
standard deviation is pooled using a simple moving rectangular window of 501 spots, but other
window sizes and shapes may improve performance slightly. More generally, we have not
explicitly compared the moving average estimator with the spline-fit or loess-based techniques to
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estimate the standard deviation used in other studies (see Background). While we expect
performance to be similar, further testing may reveal an advantage.
Following Ref. [92], we do not try to estimate the dye-specific bias of individual spots or
genes (i.e., dye- gene interaction) in order to preserve degrees of freedom needed to estimate the
variance. Informally we noted that dye bias in some spots produced high measured variances
that caused those spots to be considered non-significant outliers. A post-hoc test to warn of
potential dye bias of individual spots may be appropriate for small numbers of array replicates
(e.g. N=3), especially if the experimental design is unbalanced (i.e., the number of dye-swapped
and unswapped arrays is not equal).
Note that this study only considered statistics of the general form (ratio) / (standard
deviation). ANOVA models that consider the variance as intensity-dependent, as seen in Ref.
[68, 78], can be seen as an extension of this concept. An ANOVA framework, however, also
allows for a more complicated experimental model that can incorporate normalization and
multiple biological conditions. Pooling standard deviations as a function of minimum intensity
instead of average intensity may benefit such models. Permutation tests can also be used to
detect regulated genes, and are known to be robust to outliers but can have low power for small
N. Xu et al. found a permutation test to be equally or less accurate than parametric methods in
ranking genes [93]. Bayesian analysis can also be applied to microarray data [66, 73, 74], and
may be useful in this context to draw more information out of the distribution of intensities and
ratios in the data.
In this study, data is first normalized, and then detection of regulated genes is performed
in a separate step. In contrast, other approaches incorporate normalization and statistical
inference into a unified model [82, 92]. Furthermore, the options for normalizing the data are
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numerous, including algorithms based on local regression (loess) [60], splines [94], a constant
shift [68], or more exotic transforms that tend to remove the intensity dependence of the variance
[95]. Increased attention to the low-level details of scanning and image processing may also
improve accuracy [75, 90, 96], while at the same time potentially changing the intensity
dependence of the variance. It remains to be seen how the techniques used for normalization or
variance-stabilizing transforms will impact the accuracy and precision of regulated gene
detection. In addition, we are concerned that some of these transforms may create a systematic
bias for or against genes of low intensity (e.g., [97]).
3.4.7. Test performance can depend on data characteristics. Although many datasets have
a variance that is intensity-dependent [65, 68, 74-79], some studies have analyzed datasets whose
variance characteristics are not strongly intensity-dependent (e.g., [92]). In general, we have
experienced that microarray datasets with a low background relative to signal, loess-based
normalization, and conservative background subtraction (e.g. SPOT Image Processing) produce
standard deviations that are not strongly intensity-dependent. In this context, the differences
between the I,, and Iavg metrics disappear. In fact, for data with unusually low noise, the
standard deviations is nearly constant across all spots and all of the statistical tests considered in
this paper, even simply the average logged ratio, tend to converge. This observation is not
unexpected; as the standard deviations converge to the same value, the denominator of the test
statistics will become constant, leaving the test statistics simply proportional to the ratio. We
would recommend finding a normalization [60, 82, 90, 94] and background subtraction
technique [75, 86, 96] that produces low, intensity-independent standard deviations. Applying
variance stabilizing transforms may eliminate the intensity dependence of the standard deviation
[95], but might also reduce statistical power or bias the test toward spots of certain intensities. It
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cannot be predicted in advance whether all intensity dependence of the variation will be
removed, so we continue to use the more robust statistic Z(Imin) for all of our datasets.
Furthermore, in situations where changing the background subtraction or normalization
technique is not possible because the original data is not available, using a more robust statistic
like Z(Imin) will be advantageous.
While the pooling techniques described herein can compensate for intensity-dependent
variation, this intensity dependence can be minimized or exaggerated by different normalization
techniques and background subtraction techniques. These techniques may have subtle effects on
the power to detect regulated genes at different intensities, perhaps creating bias for or against
detection of low-expressed genes. For this reason, until the most sensitive and unbiased
normalization and background subtraction methods are optimized for each microarray system,
we would encourage creators of microarray data archives to preserve unnormalized intensity and
background data, and the original image data when possible.
Of the many useful tests used to detect regulated genes from a small number of
microarray replicates, we see the intensity-based variance estimation and Z-statistic described
here to be a good combination of simplicity, robustness, precision, and accuracy. This technique
allows meaningful p-values to be added to a list of regulated genes. With this assessment of
statistical significance, an investigator can proceed to focus on genes that are most likely to be
regulated. Implementations of the Z-test algorithms are available at
http://vessels.bwh.harvard.edu/software/papers/bmcg2004.
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4. The Transcriptional Response of Cultured HUVEC to IL-1 P
4.1. The Response of HUVEC to an Inflammatory Stimulus
The changes caused by an external stimulus to the genome-wide basal expression profile
of cultured HUVEC (cf. Chapter 2) can be studied using the statistical algorithms detailed in the
previous chapter. The stimulus we have chosen to study here is interleukin-1 beta (IL-13), a
potent inflammatory stimulus for endothelial cells [98]. Responding to inflammatory stimuli is
one of the most critical roles of the endothelium, as it is the capillary and venule barrier that
regulates extravasation of leukocytes into tissues. By overseeing leukocyte tethering and
migration, and amplifying or abrogating signaling cascades, endothelial cells modulate the effect
and severity of an inflammatory response. In addition, a number of other roles of endothelium-
e.g., regulation of haemostasis and control of permeability -are modulated during
inflammation. Thus, a genome-wide endothelial snapshot of endothelial cells exposed to an
inflammatory stimulus will begin to provide insight into the complex regulatory networks that
comprise the genetic control of several endothelial cell functions. Understanding the nature of
this response also provides insights into targets for clinical manipulations in the context of
sepsis, atherosclerosis, autoimmune disorders and other inflammatory pathologies.
4.2. Methods
4.2.1. Experimental conditions. We chose to stimulate cells with IL-10 (10 U/mL) in our
in vitro model of inflammation as it has been well-characterized in our laboratory as a potent
inflammatory stimulus [98]. HUVEC isolated from normal term cords and pooled from 5 to 7
donors were cultured in complete media supplemented with 20% fetal calf serum, 2mM L-
glutamine, 50 mg/ml endothelial cell growth supplement, 100 mg/ml heparin and 100 unit/ml
penicillin-G1100 mg/ml streptomycin, and incubated at 370C in 5% C02 in humidified air.
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Cells from the first subculture were plated at an initial density of 70,000 cells/cm 2 and grown for
24 hours. At this time point, the cells were exposed for 4 hours either to IL-1 at a concentration
of 10 U/mL ("IL-1"), or to media ("control"). These paired experiments were repeated with
three independent batches of HUVEC. RNA from these cells was collected and microarrays for
each sample were prepared as described in Chapter 2.
4.2.2. Image Quantification and Statistical Processing. The images produced by the
AB 1700 scanner were quantified by the scanner software, which subtractively normalizes each
spot's chemoluminescent signal against a corresponding fluorescent control signal, provides
surrogate values for negative or especially faint spots and normalizes all the values in an attempt
to map intensities from each array to a uniform dynamic range. In contrast with the expression
profile analysis, the normalized and surrogated signal values were used to enable the calculation
of meaningful, non-negative ratios (although these ratios may be underestimates for surrogated
values). We observed that when comparing any two microarrays, there was usually a bias in
signal values towards one array over the other at high intensities. Thus, before comparing any
two arrays to each other, we applied an intensity-based Lowess correction to normalize the array
values [60]. Spots with flag values over 10,000 were excluded from analysis, and all remaining
genes, whether classified as expressed or not expressed in cultured HUVEC (cf. Chapter 2), were
retained. Genes differentially expressed between the two conditions, IL-1 and control, were
statistically identified by applying the minimum-intensity-based variance estimation technique
with outlier detection described in Chapter 3 to the three Lowess-normalized pair of replicates.
4.2.3. QRT-PCR Validation of Select Genes. Ninety-five genes known to be involved in
inflammatory processes were validated using real-time quantitative Taqman PCR with the same
three pairs of RNA samples used to generate the microarray data. Briefly, the purified, DNase-
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treated RNA (1.5 gig) was reversed-transcribed by using a MultiScribe based reverse
transcription reaction (Applied Biosystems). The cDNA were then subjected to a real-time
TaqMan PCR in a GeneAmp 5700 sequence detection system (Applied Biosystems). The
relative gene expression was normalized to 18s RNA.
4.3. Results
4.3.1. Validation of Statistical Techniques. To validate the results presented in Chapter 3 for this
single-channel array platform, the microarray data were processed using both the minimum and
average-intensity-based variance estimation algorithm without outlier detection. The average
residual error for spots whose actual standard deviation fell below the pooled standard deviation
was 0.23 using the minimum intensity metric and 0.25 using the average intensity metric; the
average residual error for spots whose actual standard deviation fell above the pooled standard
deviation was 0.17 using the minimum intensity metric and 0.19 using the average intensity
metric. Thus, the minimum intensity metric produced a slightly better fit than the average
intensity metric.
4.3.2. Genes Transcriptionally Regulated by IL-I in HUVEC. Fig. 4.1 plots the average
intensity of spots from the IL-1 arrays against the average intensity of the corresponding spots
from the control arrays, with statistically significantly regulated genes highlighted in color.
Overall, 491 genes (523 spots) were upregulated by the IL- stimulus and 259 genes (275 spots)
were downregulated by the IL-1 stimulus. These numbers indicate that approximately 4.7% of
the human genome is transcriptionally regulated in HUVEC by IL-1. The list of all these genes
is found in Appendix A.
Fig. 4.2 shows the physical chromosome location of annotated up- and down-regulated
genes. These genes are distributed throughout the genome, with notable clusters at on
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Fig. 4.1. Scatteiplot of average spot intensitiies for control vs. IL-I treated samples. Statistically significant
differentially expressed genes highlighted in color.
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Simplified Panther Function Genes Genes Genes Genes
Transcription factor 51 49 10.4% 18.9%
Nucleic acid binding 12 13 2.4% 5.0%
ytoskeletal protein 12 11 2.4% 4.2%
Cytokine 18 0 3.7% 0.0%
Myelin protein 17 7 3.5% 2.7%
G-protein 17 6 3.5% 2.3%
Defense/immunity protein 17 2 3.5% 0.8%
Kinase 15 8 3.1% 3.1%
Transporter 12 7 2.4% 2.7%
Receptor 12 7 2.4% 2.7%
Phosphatase 12 1 2.4% 0.4%
Signaling molecule 11 4 2.2% 1.5%
Cell adhesion molecule 11 3 2.2% 1.2%
Protease 11 2 2.2% 0.8%
G-protein coupled receptor 6 5 1.2% 1.9%
Transferase 9 4 1.8% 1.5%
Chaperone 8 2 1.6% 0.8%
Oxidoreductase 8 2 1.6% 0.8%
Chemokine 8 0 1.6% 0.0%
Cytokine receptor 8 0 1.6% 0.0%
Membrane traffic protein 7 3 1.4% 1.2%
Extracellular matrix 6 0 1.2% 0.0%
Membrane-bound signaling molecule 5 3 1.0% 1.2%
Transfer/carrier protein 5 2 1.0% 0.8%
Kinase modulator 5 1 1.0% 0.4%
Protease inhibitor 4 0 0.8% 0.0%
Growth factor 3 2 0.6% 0.8%
Cell junction protein 3 2 0.6% 0.8%
Select calcium binding protein 2 2 0.4% 0.8%
Protein kinase receptor 1 2 0.2% 0.8%
Isomerase 0 2 0.0% 0.8%
Synthase and synthetase 3 1 0.6% 0.4%
Hydrolase 3 1 0.6% 0.4%
Ligase 2 1 0.4% 0.4%
Ion channel 2 1 0.4% 0.4%
Transmembrane receptor regulatory/adaptor protein 0 1 0.0% 0.4%
Peptide hormone 0 1 0.0% 0.4%
ther enzyme regulator 1 0 0.2% 0.0%
Storage protein 1 0 0.2% 0.0%
Phosphatase modulator 1 0 0.2% 0.0%
Select regulatory molecule 1 0 0.2% 0.0%
Lyase 0 0 0.0% 0.0%
Structural protein 0 0 0.0% 0.0%
Surfactant 0 0 0.0% 0.0%
Viral protein 0 0 0.0% 0.0%
Table 4.1. Summary of simplified Panther classifications for annotated genes
determined to be statistically regulated by IL-I in cultured HUVEC.
69
* Upregulated Genes
i m Downregulated Genesj
ILLLL , LL,.... IIIi....
Fig. 4.3. Histogram illustrating the number of IL-l-upregulated (red) and downregulated (blue) genes on the array
associated with each simplified Panther category.
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chromosomes 4, 6, and 11. The chromosome 4 cluster includes upregulated chemokines IL-8,
and CXCL1, 2, 3, 5 and 6. The chromosome 16 cluster includes upregulated genes ubiquitin D,
MHCI-HLA-A and E, ABCF1 and IER3. The chromosome 11 cluster includes 3 upregulated
genes-BIRC2 and 3, and MMP10, as well as the downregulated metalloprotease MMP13.
Given such a large number of genes, it is useful to group them into functional categories
based on the simplified Panther categories described in Chapter 2. Of the 750 regulated genes,
439 were associated with one or more simplified categories, as given in Table 4. 1; Fig. 4.3
presents a bar graph showing the number of regulated genes found in each category. Most
categories contain both up- and down-regulated genes, while a few contain only upregulated
genes.
4.3.3. Select QRT-PCR Validation of Microarray Results. Of the 95 genes validated by QRT-
PCR (see Table 4.2), 20 were found to be significantly regulated using a t-test on the 3 replicate
logged PCR ratios. These 95 PCR probes corresponded to 108 microarray spots (due to
duplicate spots for a given gene). Of the 21 spots that corresponded to a statistically regulated
gene by PCR, 14 (sensitivity of 67%) were detected as statistically significantly regulated on the
microarrays. Of the 7 genes that were not detected on the microarrays, 3 had average ratios
greater than 2, but were not statistically detected due to noise and another 3 had ratios less than 2
fold by PCR. Interferon gamma was the only validated gene regulated greater than 2x (22.9
fold) by PCR and not detected by microarray. Of the remaining 87 spots that corresponded to a
non-regulated gene by PCR, 3 (false positive rate of 3.4%) were detected as statistically
significantly regulated on the microarrays. Of note, all 3 of these genes were regulated by 1.9-
fold or higher on PCR, but results were too variable to be found statistically significant. Since
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the PCR was performed specifically on genes associated with the inflammatory process, the
specificity may be artificially high.
Avg Direct
PCR Labeled
Name Ratio Ratio
CSF2 630.6 518.1
CSF3 595.1 51.4
SELE 471.1 432.2
CXCL10 176.6 9.2
MCP1 122.4 107.8
ICAM1 71.0 64.0
IL8 69.2 58.9
TNF 49.3 2.0
IFNg 22.9 -1.2
IL6 21.8 23.8
ILb 11.1 6.6
ILla 10.5 16.9
NFKB2 8.8 11.1
IL15 7.9 7.1
CSF1 7.2 10.1
CSF1 7.2 6.0
MADH3 2.1 2.4
LTA 1.8 1.3
MADH7 -2.2 -1.7
CD68 -1.3 1.2
ACE -1.2 - 1.1
CCL5 17.4 2.2
CXCL11 2.8 .2 
IL12A 2.4 -1.1
TNFRSF18 2.2 1.2
VEGF 2.2
CYP7A1 2.0 -1.5
PTGS2 1.9 _ _ ,'
IL7 1.6 1.2
IL7 1.6 -1.2
IL7 1.6 -1.2
CCR4 1.4 -1.1
CD28 1.2 1.1
IL18 1.1 -1.3
EC1 1.1 1.4
CD38 1.1 -1.1
Avg Direct
PCR Labeled
Name Ratio Ratio
Stat3 1.1 1.2
Stat3 1.1 1.3
Stat3 1.1 1.1
CCL3 -3.6 -1.2
CCL3 -3.6 -1.5
CCL3 -3.6 2.1
PRF1 -3.1 1.1
CXCR3 -3.0 -1.4
PTPRC -2.7 1.1
PTPRC -2.7 -1.0
CD3 -1.9 -1.5
BCL2 -1.8 -1.1
BCL2 -1.8 -1.0
COL4A5 -1.7 -1.0
IL5 -1.6 -1.1
IkB2 -1.5 1.0
SKI -1.5 -1.1
AGTR1 -1.5 -1.1
GZMB -1.5 -1.2
HMOX1 -1.4 -1.2
GNLY -1.4 -1.3
TNFRSF6 -1.4 -1.1
ACTB -1.3 -1.1
HLADR -1.3 1.4
TGFB1 -1.3 -1.1
Nos2A -1.3 -1.8
BAX -1.3 1.1
BAX -1.3 1.1
CD8 -1.3 1.6
CD8 -1.3 1.6
SELP -1.3 1.0
TFRC -1.2 -1.1
CD34 -1.2 1.0
GUSB -1.2 -1.2
EDN1 -1.1 -1.1
FN -1.1 1.1
Avg Direct
PCR Labeled
Name Ratio Ratio
TNFRSF5 -1.1 1.2
GAPDH -1.1 -1.0
GAPDH -1.1 -1.1
TBX21 -1.0 -1.0
BCL2L1 -1.0 1.1
C3 -1.0 1.2
AGTR2 n/a -2.2
CCL19 n/a 1.2
CCR2 n/a 1.2
CCR5 n/a 1.2
CCR7 n/a -1.0
CD19 n/a -1.1
CD4 n/a -1.2
CD80 n/a 1.8
CD86 n/a -1.1
CTLA4 n/a 1.6
CYP1A2 n/a 1.3
HLADRA n/a 1.0
Hs00411908 n/a -1.0
ICOS n/a 1.5
ICOS n/a 2.0
IL10 n/a 1.8
IL12B n/a -1.0
IL13 n/a -1.4
IL17 n/a 1.2
IL2 n/a -1.2
IL2RA n/a 1.4
IL3 n/a 2.2
IL4 n/a -1.0
IL4 n/a 1.2
IL9 n/a 2.7
LRP2 n/a 1.4
REN n/a 1.2
RPL3L n/a -1.2
TNFSF5 n/a 1.3
TNFSF6 n/a -1.4
Table 4.2. Average IL-I to control expression ratios in cultured HUVEC as determined by RT-PCR and microarray
for a select set of inflammation-related genes. Ratios in bold were determined to be statistically significant.
Microarray results that agree with PCR data are shown in red (regulated) and blue (not regulated) and results that
disagree with PCR data are shown in pink (not regulated on microarray) and cyan (regulated on microarray). A
value of "n/a" indicates RNA levels in both samples were undetected by PCR for more than 1 replicate.
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4.4. Discussion
4.4.1. Comparison to Basal Expression Profile. Of the 750 genes regulated by IL-1, 701
genes were found to be expressed by the statistical analysis detailed in Chapter 2. Thus, only 49
(10%) of the upregulated genes, are "turned on" from a non-expressed state; the others are
already "on" and their expression is only modulated. Although this number may be an
underestimate due to false positives from the expression analysis, it does reflect that the majority
of genes involved in mediating the endothelial inflammatory response are transcribed basally.
Thus, the response appears not so much to switch on the activation of completely silent
pathways, but rather to amplify the processes of already enabled pathways.
Interestingly, there is a bias towards upregulation of genes over downregulation in
response to an IL-1 stimulus. The gene expression profile of cultured HUVEC (cf. Chapter 2)
indicates that the majority of highly expressed genes under basal conditions are those required
for basic cellular function (e.g., transcription) or key endothelial function (e.g., hemostasis).
Thus, the scope for modulating phenotype by downregulating these genes without impairing
necessary functions is limited. In fact, in Panther functional categories that contain a number of
highly expressed genes that may not be critical for cell survival or identity--e.g., transcription
factors or cytotskeletal proteins-there are comparable numbers of IL-1 upregulated and
downregulated genes. For the most part, however, the endothelial cell under basal conditions
appears to activate at high levels only critical pathways, and responds to stimuli by amplifying
additional pathways.
4.6.2. Biological roles of regulated genes. A number of the genes found to be regulated
have previously been shown to be IL-1 responsive in HUVEC, such as the upregulation of cell
adhesion molecules including ICAM-1, VCAM-1 and E-selectin [99],[100], cytokines such as
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IL-6, IL-8, MCP-1, and GM-CSF [99], pro-thrombotic factors such as tissue factor, and the
downregulation of anti-thrombotic factors such as thrombomodulin [101] and the glycoprotein
thrombospondin [102]. The Panther classifications underscore their patterns; the largest
categories containing only upregulated genes are cytokine, chemokine and cytokine receptor and
categories highly enriched in upregulated genes include defense/immunity protein.
A number of genes not previously recognized to be regulated by IL- were also
discovered in this dataset. These genes include upregulated transcripts, but downregulated genes
are of especial interest in this genome-wide study since previous studies on the effect of IL-1 on
endothelial cells have focused primarily on which gene products are upregulated by the
inflammatory stimulus, and report far more upregulated than downregulated genes [5, 103]. As
noted earlier, the largest number of downregulated genes fall in the transcription factor, nucleic
acid binding and cytoskeletal protein Panther categories (see Fig. 4.3).
Two Kruppel-like factors, KLF3 and KLF7, are upregulated by IL-1. KLF7 has been
shown to be upregulated in HUVEC by IL-1 at other time points [5], but this study is the first to
note upregulation of KLF3. Interestingly, KLF2, which shares a close homology with these
other factors, is downregulated by IL-1. While KLF2 has been characterized as an anti-
inflammatory transcription factor [36], the others have not been implicated functionally in any
inflammatory process to date.
Several TNF-alpha-induced proteins (TNFAIP's) and TNFAIP-interacting proteins,
which appear to have a net anti-inflammatory and cytoprotective effect, are upregulated in our
dataset. TNFAIP2, 3, and 6 have been shown to be regulated by IL- in previous transcriptional
profiling studies as well [5, 103]. Our dataset also includes the upregulation of TNFAIP1 and 8,
as well as TNFAIP3 interacting proteins 1, 2 and 3. The roles of TNFAIP1, 2 and 8 are not well
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characterized; TNFAIP3 has been shown to inhibit NF-Kappa B activation and apoptosis [104]
and TNFAIP6 activates inter-alpha-inhibitor, an anti-inflammatory agent [105]. TNFAIP3
interacting protein 2 (TNIP2) inhibits endothelial apoptosis [106]. In contrast, TNIP1 appears to
attenuate ERK2 signaling, which may have a pro-apoptotic effect [107]. TNIP3, which was
among the top 50 upregulated genes (11.8x), is a cytoskeletal protein whose only known role is
its induction by Listeria in macrophages [108]. Thus, IL-1 appears to activate in concert the
transcription of several related and possibly redundant genes preventing apoptosis, perhaps as a
part of a negative feedback loop.
The Notch pathway has previously been shown to inhibit the NF-Kappa B pathway [109],
which plays an important role in mediating inflammatory responses. It has also been shown to
be activated under TNF stimulation in the context of rheumatoid arthritis [110]. Notch ligand
jagged 1 has been seen as upregulated in HUVEC by IL-1 in previous transcriptional profiling
studies, but our dataset indicates that several other genes related to the Notch pathway are
regulated in HUVEC by IL-1 at the 4-hour timepoint. The downstream Gridlock homolog Hey-i
is upregulated (1.5 fold), along with Notch activator presenilin 1 (1.6 fold) and Notch ligand
jagged 1 (2.6 fold). The ligand jagged 2, however, is downregulated (1.7 fold). The increased
expression of Notch pathway members under IL- stimulation may indicate a negative feedback
loop to moderate the NF-Kappa B response.
The Notch pathway, which is involved in vascular development, may also be regulated as
part of an angiogenic response to an inflammatory stimulus. Concurrent regulation of other
developmental or angiogenesis-related genes include both Ephrin Al and B1, which were
upregulated (4.3 and 2.5 fold, respectively), and Ephrin ligand EphA4, which was downregulated
(1.7 fold). The Ephrin-Eph genes have been implicated mostly in development and angiogenesis
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[111], and their regulation under IL-1 suggests either that even at an early time point, this
stimulus causes endothelial cells to modulate their angiogenic phenotype. Several other known
or putative pro-angiogenic factors were found to be upregulated, including the cytokine IL-8,
VEGF, and adrenomedullin [112]. In contrast, another angiogenic factor, placental growth factor
[113], was downregulated.
Atherosclerosis, considered to be an inflammatory process, also includes the
accumulation of many lipids in its lesions. Interestingly, two species of apolipoprotein L are
upregulated by IL-1 in cultured HUVEC. Apolipoprotein L has previously been demonstrated to
be upregulated in a TNF-alpha-induced endothelial inflammatory response and to be present in
atherosclerotic lesions [114]. Also upregulated (1.6 fold) is seipin, the gene implicated in
Bernardinelli-Seip congenital lipodystrophy; loss of function of this gene leads to loss of fat
accumulation [115]. Upregulation of this gene in endothelial cells may be involved in the lipid
dysregulation that is often seen in the context of vascular inflammation.
Suprisingly, also upregulated is EDG-1, a molecule implicated in angiogenesis and
formation of adherens junctions in endothelial cells [116], although increased permeability
would be an expected endothelial response to an inflammatory stimulus. Perhaps this gene is
upregulated as part of a negative feedback loop in response to the increased permeability one
would expect to find in an endothelial inflammatory response.
4.6.3. Advantages of Genome-wide Screening of Differential Gene Expression. The
ability to interrogate the entire genome for changes in HUVEC gene expression due to IL-
stimulation has revealed a number of new genes regulated, such as KLF2, Ephrin B1, HEY-1 and
jagged 2, in addition to several genes known to be IL-1 responsive such as E-selectin, VCAM
and IL-8. This study is the first to look at the effect of IL-1 stimulation of HUVEC with total
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genome array technology and with replicate measurements. Comparisons with other studies are
confounded by the use of different time points and experimental conditions such as IL-1 dosage
and source of endothelial cells [5, 103, 117]. Compared to the two closest studies that profiled
HUVEC treated with IL-1 10 U/mL across a range of time points [5, 103], this study has found
far more regulated genes, and a greater percentage of downregulated genes. Zhao, et al. looked
only at a subset of the genome, 4,000 genes, and found 33 genes to be regulated in at least 1 of 5
different time points, of which 10% were downregulated at 4 hours [103]. Mayer, et al. used a
more comprehensive genome array examining approximately 30,000 genes, and found 137
regulated genes in at least 1 of 3 different time points, of which approximately 10% were
downregulated. Our previous transcriptional profiling experiments with non-total-genome arrays
(using identical experimental conditions and comparable statistical processing) have also
produced a smaller number of regulated genes and smaller fraction of downregulated genes
[118]. The bias towards upregulated genes may indicate that previous arrays that spotted a
limited number of genes were enriched in genes characterized as having increased expression
under activating stimuli.
One factor affecting the overall high numbers of regulated genes that we found at just one
time point compared to other studies is our use of replicate microarrays and statistical analysis.
Instead of setting arbitrary fold cutoffs, we have been able to select genes according to a
statistical cutoff of the likelihood of their being truly regulated. Thus, we are not limited by the
size of ratios, e.g., 4x in Mayer, et al.'s study, and can detect important genes that are regulated
at lower fold differences but consistently so. Such genes include both upregulated species such
as apolipoprotein L2 (3.3x), TNFAIP3 interacting protein 2 (1.8x), the apoptosis-related caspase
7 (1.7x) and downregulated species such as connexin 37 (2.8x) and thrombospondin (-1.9x). The
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use of replicates also reduces the number of false positives in our lists of differentially regulated
genes, since reproducibility is taken into account. The reliability of our statistical approach is
reflected in the PCR data, especially in the high sensitivity (96.6%).
In addition to unveiling additional genes regulated under an inflammatory stimulus, a
genome-wide exploration of the HUVEC response to IL- has enriched the existing knowledge
we have of which pathways are affected by this stimulus. For example, jagged 1 expression has
been previously shown to be regulated by IL-1, but this study is the first to illustrate the
concomitant regulation of several other elements of the Notch pathway. Similarly, a number of
additional molecules in the TNFAIP family and the Ephrin/Eph family have been newly shown
to be regulated by IL-1. These results underscore the complexity of the endothelial response to a
simple chemical stimulus; both receptors and ligands, as well as genes with overlapping
function, are regulated at a transcriptional level. Such results can be used to discover novel DNA
binding sites for transcription factors that affect multiple genes regulated by IL-1 [5].
Perhaps most revealing from a genome-wide study of the endothelial response to a simple
stimulus are the conflicting directions in which genes involved in the same pathway or function
are regulated. The contrasting regulation of jagged 1 and 2, or of the pro-angiogenic VEGF and
anti-angiogenic placental growth factor, highlights the complexity of the feedback mechanisms
that are activated in response to IL-1. By further defining the genome-wide expression profiles
of HUVEC responding to the same stimulus at different time points, as well as to different
stimuli that modulate some of the same pathways, will provide the data required to reverse
engineer these rich regulatory transcriptional networks.
78
5. Effect of Linear Amplification of RNA on Microarray Analysis
5.1. Introduction
The genome-wide expression profiling techniques we have described can be applied to
the study of an endless spectrum of tissues and conditions, limited only by sample availability. It
may be difficult to obtain sufficient RNA material (-40 .g of total RNA) to perform a
microarray hybridization using patient biopsy specimens or under certain experimental
conditions. RNA amplification techniques have been developed to allow enough labeled
material to be generated starting from only 1-10 gg of RNA, a fraction of the material required
for a direct-labeling experiment [119].
RNA amplification techniques must be mostly linear to be of use in a differential
expression study. Although most RNA amplification techniques have been demonstrated to act
linearly across a broad range of concentrations [120, 121], there is undoubtedly an introduction
of additional noise via the amplification processes [122]. For example, the amplified RNA
sample may be enriched in shorter RNA sequences due to preferential transcription or
degradation [123]. RNA amplification has higher fidelity on the 3' end of an mRNA compared
to the 5' end; thus genes queried with probes that represent the 5' end may not be accurately
detected on microarrays [124, 125]. Some of these systematic biases affect both control and
treated samples and may have only a minor effect on the ratios of gene expression between
conditions. Concentration biases may have a larger impact on differential expression studies. If
the amplification factor is greater for species at lower concentrations than for those at higher
concentrations, the differential expression ratios will be damped by the amplification process. If
the reverse is true, genes whose transcript levels differ only slightly may appear to be strongly
regulated. To characterize the effect of amplification on our expression profiling results, we
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compared results from our original data and from microarrays using material amplified from the
same original RNA samples.
5.2. Methods
5.2.1. RNA isolation. RNA from IL-1 treated and control HUVEC was isolated and
quantified in triplicate as detailed in Chapter 4. The same RNA was used for reverse
transcriptase - in vitro transcription (RT-IVT) amplification so that the effects of amplification
could be compared to the data from the original biological specimen.
5.2.2. Amplification and Hybridization. RT-IVT amplification was performed for each
sample according to manufacturer's protocols (all reagents supplied by Applied Biosystems,
Foster City, CA, unless otherwise specified). Briefly, first a reverse transcription amplification
process generated cDNA from 10 tg of original total RNA. The total RNA was mixed with 2.0
ptL T7-oligo (dT) primer and 4.0 [tL control RNA, then heated to 700 C for 5 min. and cooled to
4°C. 2.0 ptL 1OX First Strand Buffer Mix and 3.0 tL RT Enzyme Mix were added and the
reaction held at 25C for 10 min., 42°C for 2 hours, 70°C for 15 minutes and then cooled to 4°C.
Second strand DNA was generated by adding 95.0 1tL nuclease-free water, 30.0 tL 5x Second
Strand Buffer and 5.0 tL Second Strand Enzyme Mix, and this reaction was held at 16°C for 2
hrs., 70°C for 15 min. and cooled to 4°C. Double-stranded DNA was then purified by the
addition of 150 tL of DNA Binding Buffer, followed by transfer to a DNA purification column,
two washes with 700 glL each of DNA Wash Buffer and finally three elutions with 30 [tL each of
DNA Elution Buffer.
Labeled cRNA for microarray hybridization was generated from 15 tL of the purified
cDNA. 11 [tL nuclease-free water, 8.0 jtL 5x IVT buffer, 4.0 CtL digoxigen-1 1-UTP (Roche) and
2.0 iiL IVT Enzyme Mix were added to the cDNA and reacted at 37°C for 9 hrs. then cooled to
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4°C. Labeled cRNA was then purified by the addition of 20 tL nuclease-free water, 200 pL
RNA Binding Buffer and 140 gtL 100% ethanol, transfer to an RNA purification column, two
washes with 500 4tL each of RNA Wash Buffer and finally two elutions with 50 tL each of RNA
Elution Buffer. Quality of the cRNA was verified with the Agilent Bioanalyzer 2100, and
absorbance of a 1:30 dilution of the purified cRNA was measured at 260 nm and 320 nm to
calculate cRNA concentration as (A260 - A320)*1.2. 10 ptg of cRNA in 80 jtL of nuclease-free
water was combined 10 tL cRNA Fragmentation Buffer, heated to 600C for 30 minutes then
stopped by addition of 50 ptL of cRNA Fragmentation Stop Buffer. 150 tL of this fragmented
labeled cRNA was used in the microarray hybridization procedure as detailed in Chapter 2.
Normalized, surrogated values were used for comparison of individual replicate data and of
differential expression analyses; recovered unsurrogated values (see Chapter 2 methods) were
used for expression profile analysis.
5.3. Correlation of RT-IVT Signal Values with Non-Amplified Signal Values
For each replicate in each condition, the set of signal values from the RT-IVT microarray
was compared to its corresponding set of non-amplified signal values, resulting in squared
Pearson's linear correlation coefficients (R2 ) of 0.65 to 0.67. If signal values are biased similarly
for samples from both conditions, then the ratios may still be valid. For each replicate, the set of
ratios after Lowess-normalizing between conditions were compared between the direct and RT-
IVT datasets, resulting in fitted slopes of 1.0, 0.93 and 1.1 and R2 of 0.05, 0.65 and 0.16 for
replicates 1, 2 and 3 respectively. This poor correlation, however, appears to be due to a small
number of false classifications and many small differences in the ratios of non-regulated genes.
Fig. 5.1, which plots the corresponding RT-IVT and direct ratio values against each other for
each replicate, illustrates that there are a similar number of points for all three replicates where
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Fig. 5.1. Plots of corresponding IL-1 to control signal ratios from the RT-IVTdataset vs. the
direct labeled dataset. (a) Replicate #1. (b) Replicate #2. (c) Replicate #3.
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the log ratio magnitude is large in the direct dataset, but small for the RT-IVT dataset (scatter
parallel to the x-axis), representing false negatives. Examining false positives, however, there
are a number of points in replicates #1 and #3, compared to replicate #2, that have small log ratio
magnitudes in the direct microarray dataset but large log ratios magnitudes in the RT-IVT
dataset. The largest ratios lie close to the y=x line for all replicates; thus the behavior of the most
regulated genes appear to be accurately captured when using RNA amplification.
5.4. Expression Analysis with RT-IVT Data
The gene expression profile analysis detailed in Chapter 2 was repeated using the RT-
IVT microarray data from control samples. Parameter values for the theoretical distributions and
the RMS errors between the theoretical and actual distributions are given in Table 5.1. Most
noticeably, the Gaussian standard deviation values are larger, suggesting that the RT-IVT signal
values for non-expressed genes are noisier and fall in a broader range of values that direct signal
values. Thus, the expressed and non-expressed distributions have a greater overlap and are
harder to separate absolutely. The increased noise reduces the fraction of spots predicted to be
expressed for each replicate, from -60% to -50% (f = 0.42 - 0.50). Selecting spots for which all
good quality replicates were classified as expressed (using cutoffs that maximized the theoretical
true classification rate), a total of 17,848 spots (53.9% of all spots on array) representing 15,914
genes (53.4% of all genes on array) were considered to be expressed. 83% of the spots originally
classified as expressed were also classified as expressed based on the RT-IVT data. 3,141 spots
classified as expressed based on the unamplified microarray data were not classified as expressed
using the RT-IVT data (e.g., taxilin, with an average signal value of 141.08 vs. 0.26), and 2,517
spots were newly classified as expressed based on the RT-IVT data (e.g., the chemokine CCL3,
with an average signal value of 31.40 vs. 0.87). Thus, the majority of genes are classified
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consistently as expressed or non-expressed under both direct labeling and amplification
conditions.
Replicate #1 #2 #3
Minimum signal value -3.49 -4.36 -2.44
Maximum signal value 1457.66 2634.80 2647.40
f 0.42 0.47 0.50
9N 0.06 0.12 0.21
ON 0.33 0.44 0.45
1.47 1.67 1.58
(E 1.76 1.72 1.60
x0 0.39 0.56 0.69
RMS Error 8.3E-03 9.2E-03 7.7E-03
ML Cutoff 0.59 0.86 1
True Classification
Rate 95.4% 95.3% 96.0%
Table 5.1. Statistics and parameter values for two-populationfit of signal intensity
distributions from 3 replicate microarrays of cultured HUVEC RT-IVT-amplified RNA.
5.5. Differential Expression of Genes
5.5.1. Differentially Expressed Genes Detected on RT-IVT Microarrays. Ultimately, it is
the net results from combining replicate data that will be used to interpret microarray data. Thus,
we compared the statistical detection of differentially expressed genes after RT-IVT
amplification to the genes detected using direct labeling. Using the same statistical algorithms
with outlier detection as applied to the unamplified microarray data, 219 genes (234 spots) were
found to be statistically significantly upregulated and 82 genes (87 spots) were found to be
statistically significantly downregulated on the RT-IVT microarrays. Fig. 5.2a highlights these
points on a scatterplot showing the average RT-IVT IL-1 intensity vs. the average RT-IVT
control intensity. Overall, a smaller number of genes (301 vs. 706) were statistically detected as
regulated. 498 genes originally detected as regulated were not found and 60 spots were newly
classified as regulated in the RT-IVT dataset; these points are circled both in the RT-IVT
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Fig. 5.2. (a) Scatterplot of average spot intensitiies for control vs. IL-I treated samples in the RT-IVTdataset. Statistically
significant differentially expressed genes highlighted in color and spots whose classification as statistically regulated differed from
the direct labeled dataset are circled in black. (b) Scatterplot of average spot intensitiies for control vs. IL-1 treated samples in the
direct labeled dataset. Statistically significant differentially expressed genes highlighted in color and spots whose classification as
statistically regulated difered from the RT-IVT dataset are circled in black.
85
100O
100
·
0.
(a)
>,
-
(b)
(I
a0)
-J(/
1000
100
·* .
o.
-
AAAA
v .I
^--
1 0&-- I I
scatterplot shown in Fig. 5.2a, as well as in a scatterplot of the original unamplified data shown
in Fig. 5.2b.
Results can vary between the RT-IVT and direct labeled methods for several major
reasons. First, non-linear amplification can cause an mRNA species present at low concentration
under one condition to be amplified by a greater factor than the same species present at a higher
concentration under the other condition. Thus, the expression ratio between conditions would be
blunted, leading to "false negative" results. Possible examples of such genes would be CSF1
(10.1x reduced to 1.3), VEGF (3.0x reduced to .lx), connexin 40 (-3.8x to -1.8 x) and connexin
37 (-2.8x to -1.5). A bias in amplification may even lead to a reverse ratio; Ephrin Al, for
example, appears to be 4.3-fold upregulated in the direct comparison dataset, but 10.7-fold
downregulated (not significant) in the RT-IVT dataset.
If the amplification bias is instead towards the higher expressed condition, however, the
expression ratio will be enhanced, possibly generating false negative values. For example,
CCL3, which was not statistically upregulated according to PCR validation (see Table 5.2),
appears to be statistically significantly upregulated by 42-fold in the RT-IVT dataset but only 2-
fold upregulated (and not statistically significant) in the direct labeled dataset. A few of the 60
"false positive" genes, however, may actually have genuinely regulated at a low level, and the
RT-IVT process, by artificially increasing the ratio, may have enhanced statistical detection of
these genes. Possible genes in this category include inflammation-related factors such as CCL7
(8.4x upregulated in the RT-IVT dataset vs. 2.4x upregulated and not significant in the direct
labeled dataset), cytokine receptor-like factor 1 (10.4x vs. -1.4x) and CD79A antigen (-.6.7x vs.
1.lx).
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The additional biochemical manipulations in the RT-IVT process change the noise
characteristics of the dataset. The overall trend is an increase in noise; thus, fewer genes are
found statistically significant. This effect can be due solely to the increased standard deviation,
seen with genes such as CXCL11 (2.8x regulated in the direct labeled dataset vs. 2.9x regulated
and not statistically significant in the RT-IVT dataset), HEY-i (1.5x vs. 1.6x), presenilin 1 (1.6x
vs. 1.7x) and jagged 2 (-1.7x vs. -1.7x). In contrast, the amplification process may
proportionally increase the concentration and therefore the intensity of a few mRNA species
under both conditions. Since standard deviations of ratios tend to be lower at higher intensities,
the RNA amplification process could actually enhance statistical detection of such genes, e.g.,
the intermediate filament binding protein plectin 1 (ratio of 18.5 to 8.9 (2x) in the RT-IVT
dataset vs. 0.2 to 0.1 (also 2x) in the direct labeled dataset). Thus, effects on ratio magnitudes
and ratio variance, as well as the combination of the two, cause the discrepancies seen between
the RT-IVT and direct labeled results.
5.5.2. Validation with PCR. Comparing the data to the PCR results given in Chapter 4,
12 out of 21 (57.1% sensitivity or true positive rate) spots representing genes shown to be
regulated by QRT-PCR and 2 out 87 (2.3% false positive rate) of the spots representing genes
not shown to be regulated by QRT-PCR are found to be statistically significantly regulated on
the RT-IVT microarrays (see Table 5.2). The sensitivity value of 57.1% is slightly worse than
the value of 67% seen with unamplified microarray data. Of the 9 "false negative" spots not
found to be regulated in the RT-IVT microarray dataset, 5 have ratios over 2-fold on RT-PCR
but under 2-fold on the microarray. This large difference in computed ratios is seen in only 1 out
7 "false negative" spots for the direct labeled dataset. The false positive rate of 2.3% compared
to 3.4% for unamplified data is not appreciably different. Of the 2 false positives, however, the
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RT-PCR dataset shows CCL3 to be upregulated by 42-fold, whereas the PCR results indicate a
non-significant 3.6-fold downregulation. None of the false positive discrepancies were of this
magnitude in the direct labeled dataset.
Avg RT- Direct Avg RT- Direct Avg RT- Direct
PCR IVT Labeled PCR IVT Labeled PCR IVT Labeled
Name Ratio Ratio Ratio Name Ratio Ratio Ratio Name Ratio Ratio Ratio
CSF2 630.6 406.9 518.1 Stat3 1.1 1.2 1.2 TNFRSF5 -1.1 1.4 1.2
CSF3 595.1 6.1 51.4 Stat3 1.1 1.1 1.3 GAPDH -1.1 -1.1 -1.0
SELE 471.1 177.6 432.2 Stat3 1.1 1.3 1.1 GAPDH -1.1 1.1 -1.1
CXCL10 176.6 11.3 9.2 CCL3 -3.6 1.2 -1.2 TBX21 -1.0 1.5 -1.0
MCP1 122.4 57.2 107.8 CCL3 -3.6 -1.1 -1.5 BCL2L1 -1.0 -1.7 1.1
ICAM1 71.0 59.5 64.0 CCL3 -3.6 42 ,3 2.1 C3 -1.0 -1.6 1.2
IL8 69.2 37.2 58.9 PRF1 -3.1 1.2 1.1 AGTR2 n/a -1.1 -2.2
TNF 49.3 -1.3 2.0 CXCR3 -3.0 1.8 -1.4 CCL19 n/a -1.3 1.2
IFNg 22.9 -1.7 -1.2 PTPRC -2.7 1.1 1.1 CCR2 n/a 1.0 1.2
IL6 21.8 31.4 23.8 PTPRC -2.7 1.4 -1.0 CCR5 n/a 1.1 1.2
ILb 11.1 8.2 6.6 CD3 -1.9 -2.6 -1.5 CCR7 n/a -1.6 -1.0
ILla 10.5 11.9 16.9 BCL2 -1.8 -1.2 -1.1 CD19 n/a 2.4 -1.1
NFKB2 8.8 2.6 11.1 BCL2 -1.8 1.1 -1.0 CD4 n/a 1.7 -1.2
IL15 7.9 8.3 7.1 COL4A5 -1.7 -1.0 -1.0 CD80 n/a -1.2 1.8
CSF1 7.2 1.3 10.1 IL5 -1.6 1.2 -1.1 CD86 n/a 1.1 -1.1
CSF1 7.2 -1.1 6.0 IkB2 -1.5 -1.1 1.0 CTLA4 n/a 1.8 1.6
MADH3 2.1 2.5 2.4 SKI -1.5 -1.1 -1.1 CYP1A2 n/a -2.3 1.3
LTA 1.8 1.4 1.3 AGTR1 -1.5 1.1 -1.1 HLADRA n/a 1.5 1.0
MADH7 -2.2 -1.6 -1.7 GZMB -1.5 -1.3 -1.2 Hs00411908 n/a 1.3 -1.0
CD68 -1.3 -1.3 1.2 HMOX1 -1.4 -1.5 -1.2 ICOS n/a -1.3 1.5
ACE -1.2 -1.6 -1.1 GNLY -1.4 1.5 -1.3 ICOS n/a 1.8 2.0
CCL5 17.4 1.8 2.2 TNFRSF6 -1.4 -1.1 -1.1 IL10 n/a -1.9 1.8
CXCL11 2.8 2.9 .: ACTB -1.3 -1.2 -1.1 IL12B n/a 1.5 -1.0
IL12A 2.4 1.3 -1.1 HLADR -1.3 -1.3 1.4 IL13 n/a 2.0 -1.4
TNFRSF18 2.2 -1.4 1.2 TGFB1 -1.3 -1.2 -1.1 IL17 n/a 1.0 1.2
VEGF 2.2 1.1 ,;,z~, Nos2A -1.3 -1.0 -1.8 IL2 n/a -1.6 -1.2
YP7A1 2.0 1.3 -1.5 BAX -1.3 -1.0 1.1 IL2RA n/a -1.2 1.4
PTGS2 1.9 f 6?', BAX -1.3 1.2 1.1 IL3 n/a 1.2 2.2
IL7 1.6 -1.3 1.2 CD8 -1.3 1.8 1.6 1L4 n/a 1.5 -1.0
IL7 1.6 -1.0 -1.2 CD8 -1.3 -1.1 1.6 IL4 n/a 1.4 1.2
IL7 1.6 -1.0 -1.2 SELP -1.3 -1.0 1.0 IL9 n/a 1.4 2.7
CCR4 1.4 -1.7 -1.1 TFRC -1.2 -1.2 -1.1 LRP2 n/a 1.1 1.4
D28 1.2 -1.0 1.1 CD34 -1.2 -1.1 1.0 REN n/a -1.2 1.2
IL18 1.1 1.0 -1.3 GUSB -1.2 -1.1 -1.2 RPL3L n/a -1.1 -1.2
EC1 1.1 1.5 1.4 EDN1 -1.1 1.0 -1.1 TNFSF5 n/a 1.1 1.3
CD38 1.1 -1.1 -1.1 FN -1.1 1.2 1.1 TNFSF6 n/a 1.3 -1.4
Table 5.2. Average IL-] to control expression ratios in cultured HUVEC as determined by RT-PCR, RT-IVT
microarray and direct labeled microarray for a select set of inflammation-related genes. Ratios in bold were
determined to be statistically significant. Microarray results that agree with PCR data are shown in red (regulated)
and blue (not regulated) and results that disagree with PCR data are shown in pink (not regulated on microarray)
and cvan (regulated on microarray). A value of "n/a" indicates RNA levels in both samples were undetected by PCR
,fbr more than I replicate.
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These qualitative differences highlight the limitations of RT-IVT amplification. With
this dataset alone, it is impossible to determine if the errors introduced by RT-IVT are systematic
or random. For example, genes certain sequences may be more prone to non-linear
amplification. Also, non-linearities may be pronounced in specific ranges of concentration.
Other datasets that directly compare direct labeling and RT-IVT data for other conditions under
which different genes are regulated may provide further insight into the nature of the incurred
noise due to RT-IVT amplification. Nonetheless, our data illustrates that this technique reliably
detects the majority of top statistically regulated genes when the amount of starting material is
limited.
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6. Conclusions
We have studied gene expression in cultured human endothelium at a genome-wide level
under both basal and inflammatory conditions. We have developed generalized analytical
techniques, both to define a comprehensive profile of expressed genes under a specific condition
and to determine statistically differentially regulated genes between two conditions. These
methods have been applied to define an endothelial transcriptome for cultured HUVEC under
basal conditions and to study the genome-wide changes to this transcriptome that are caused by
an IL-I stimulus. This analysis represents the largest snapshot of the transcriptional activity of
cultured and IL-1-stimulated HUVEC to date. Finally, we have applied these techniques to data
collected using amplified RNA samples, allowing us to characterize the effect that the additional
noise may have on the output of statistical analyses.
The tools described here can be used for the rigorous analysis of microarray data studying
any biological question. Our laboratory is currently generating genome-wide expression profiles
for different types of endothelial cells to continue developing our definition of the endothelial
transcriptome-the set of genes required for endothelial identity. By applying the differential
expression algorithms to data from more and more experimental conditions, we should enhance
our understanding of how this transcriptome is modulated by different stimuli and begin to
determine the gene regulatory networks that control endothelial structure and function. As our
new bioinformatics tools are used to explore endothelium along these two orthogonal paths-
diversity of endothelial cell origin and diversity of environmental stimuli-we will develop a
more detailed picture of the physiological and pathophysiological behavior of this vascular
interface.
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Appendix A: Genes Significantly Regulated by 4-hr. IL-113 Exposure in
Cultured HUVEC
Color corresponds to p-value indicating statistical significance:
All
Down / 5e-5 < p < .05
Down I/ 5e-10 < p < 5e-5
* Down I le-15 < p < 5e-10
.Down / p < le-15
Up I 5e-5 < p < 0.05
* Up I 5e-10 < p < 5e-5
· Up I le-15 < p < 5e-10
· Up p < le-15
Ratio Gene Name
719.7 chemokine (C-X-C motif) ligand 3
518.1 colony stimulating factor 2 (granulocyte-macrophage)
432.2 selectin E (endothelial adhesion molecule 1)
431.9 chemokine (C-X-C motif) ligand 2
352.4 vascular cell adhesion molecule 1
291.5 chemokine (C-X3-C motif) ligand 1
240.3 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
172.3 TNF receptor-associated factor 1
138.7 ubiquitin D
107.8 chemokine (C-C motif) ligand 2
100.6 chemokine (C-C motif) ligand 20
79.4 baculoviral IAP repeat-containing 3
70.8 CD69 antigen (p60, early T-cell activation antigen)
67.1 thymic stromal lymphopoietin
64.0 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
58.9 interleukin 8
51.4 colony stimulating factor 3 (granulocyte)
47.5 tumor necrosis factor, alpha-induced protein 6
45.5 tumor necrosis factor, alpha-induced protein 2
43.2 CCAAT/enhancer binding protein (C/EBP), delta
31.0 <no annotation>
29.4 chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2)
28.3 tumor necrosis factor, alpha-induced protein 3
27.5 Rho family GTPase 1
25.7 leukocyte receptor cluster (LRC) member 9
24.9 likely ortholog of rat SNF1/AMP-activated protein kinase
23.8 interleukin 6 (interferon, beta 2)
23.2 tumor necrosis factor receptor superfamily, member 9
20.4 nuclear receptor subfamily 4, group A, member 3
20.3 hypothetical protein FLJ23231
17.7 coagulation factor IIIl (thromboplastin, tissue factor)
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Ratio Gene Name
16.4 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
15.9 inducible T-cell co-stimulator ligand
13.9 <no annotation>
1 3 7 S100 calcium binding protein A3
13.6 CD83 antigen (activated B lymphocytes, immunoglobulin superfamily)
13.5 <no annotation>
12.5 molecule possessing ankyrin repeats induced by lipopolysaccharide (MAIL), homolog of mouse
12.3 chemokine orphan receptor 1
12.2 tumor necrosis factor receptor superfamily, member 1 lb (osteoprotegerin)
11.8 TNFAIP3 interacting protein 3
11.7 superoxide dismutase 2, mitochondrial
11.2 chromosome 6 open reading frame 128
11.2 <no annotation>
1 1.1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
11.0 TRAF2 binding protein
10.1 colony stimulating factor 1 (macrophage)
9.5 <no annotation>
9.4 v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (a
9.3 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
9.2 activating transcription factor 3
9.1 <no annotation>
8.8 apolipoprotein L, 3
8.4 <no annotation>
8.2 human immunodeficiency virus type I enhancer binding protein 2
8.2 jun B proto-oncogene
8.1 tenascin C (hexabrachion)
8.0 hypothetical protein MGC52057
7.9 undifferentiated embryonic cell transcription factor 1
7.8 mitogen-activated protein kinase kinase kinase 8
7.7 leukemia inhibitory factor (cholinergic differentiation factor)
7.7 interleukin-1 receptor-associated kinase 2
7.2 interleukin 18 receptor 1
7.2 nuclear receptor coactivator 7
7.1 interleukin 15
6.8 histone deacetylase 9
6.8 <no annotation>
6.7 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
6.6 receptor-interacting serine-threonine kinase 2
6.4 interferon regulatory factor 1
6.3 tumor necrosis factor, alpha-induced protein 8
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6.2 NK3 transcription factor related., locus 1 (Drosophila)
6.2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
5.9 <no annotation>
5.7 <no annotation>
5.6 TNFAIP3 interacting protein 1
5.3 <no annotation>
5.3 msh homeo box homolog 1 (Drosophila)
5.2 ATP-binding cassette, sub-family G (WHITE), member 1
5.2 antigen identified by monoclonal antibody MRC OX-2
5.2 <no annotation>
5.1 serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2
4.9 tumor necrosis factor (ligand) superfamily, member 18
4.8 BCL2-related protein Al
4.8 talin 2
4.7 Down syndrome critical region gene 1
4.7 follistatin-like 3 (secreted glycoprotein)
4.7 syndecan 4 (amphiglycan, ryudocan)
4.6 carbonyl reductase 3
4.6 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)
4 5 interleukin 7 receptor
4.5 hepatocellular carcinoma-associated antigen 66
4.5 <no annotation>
4.4 solute carrier family 2 (facilitated glucose transporter), member 6
4.4 hypothetical protein DKFZp434K0427
4.3 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
4.3 ephrin-A1
4.3 <no annotation>
4.3 sterile alpha motif domain containing 4
4.1 chromosome 8 open reading frame 4
4.1 <no annotation>
3.9 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
3.9 syntaxin 11
3.8 solute carrier family 12 (potassium/chloride transporters), member 7
3.8 <no annotation>
3.8 <no annotation>
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3.8 <no annotation>
3.8 sequestosome 1
3.7 v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
3.7 plasminogen activator, urokinase
3.6 solute carrier family 12 (sodium/potassium/chloride transporters), member 2
3.6 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
3.5 immediate early response 3
3.4 tumor necrosis factor (ligand) superfamily, member 15
3.3 <no annotation>
3.3 SRY (sex determining region Y)-box 7
3.3 DNA-damage-inducible transcript 4
3.3 apolipoprotein L, 2
3.2 glutamine-fructose-6-phosphate transaminase 2
3.2 leucine-rich repeats and immunoglobulin-like domains 1
3.1 interleukin 4 induced 1
3.1 a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 9
3.1 tumor necrosis factor, alpha-induced protein 1 (endothelial)
3.1 <no annotation>
3.1 agouti signaling protein, nonagouti homolog (mouse)
3.0 neuronal pentraxin I
3.0 metallothionein 1F (functional)
3.0 <no annotation>
3.0 sialyltransferase 1 (beta-galactoside alpha-2,6-sialyltransferase)
2.9 interferon stimulated gene 20kDa
2.9 B-cell CLL/lymphoma 6, member B (zinc finger protein)
2.9 peroxisomal proliferator-activated receptor A interacting complex 285
2.9 cytoplasmic linker 2
2.8 FOS-like antigen 2
2.8 interferon gamma receptor 1
2.8 neuron navigator 2
2.8 <no annotation>
2.8 membrane associated guanylate kinase interacting protein-like 1
2.8 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
2.8 <no annotation>
2.8 laminin, gamma 2
2.7 collagen triple helix repeat containing 1
2.7 colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
2.7 signal transducer and activator of transcription 5A
2.7 phosphoprotein regulated by mitogenic pathways
2.7 coagulation factor II (thrombin) receptor-like 1
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2.7 <no annotation>
2.7 UDP-glucose ceramide glucosyltransferase
2.7 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide
2.7 slingshot 1
2.7 solute carrier family 31 (copper transporters), member 2
2.7 hypothetical protein FLJ23375
2.7 immediate early response 5
2.7 tripartite motif-containing 47
2.6 cathepsin S
2.6 dual specificity phosphatase 16
2.6 Ras and Rab interactor 2
2.6 natural killer cell transcript 4
2.6 metallothionein 1B (functional)
2.6 elongation factor, RNA polymerase 11, 2
2.6 jagged 1 (Alagille syndrome)
2.6 calcium-binding transporter
2.6 <no annotation>
2.6 cathepsin K (pycnodysostosis)
2.6 <no annotation>
2.6 <no annotation>
2.6 phorbol-12-myristate-13-acetate-induced protein 1
2.5 <no annotation>
2.5 metallothionein IV
2.5 metallothionein 1A (functional)lmetallothionein 1KImetallothionein 1E (functional)lmetallothionein 2A
2.5 suppression of tumorigenicity 5
2.5 TRAF family member-associated NFKB activator
2.5 ninjurin 1
2.5 zinc finger protein 36, C3H type, homolog (mouse)
2.5 interferon gamma receptor 2 (interferon gamma transducer 1)
2.5 SEC14-like 2 (S. cerevisiae)
2.5 <no annotation>
2.5 <no annotation>
2.5 metallothionein 1X
2.5 CDC14 cell division cycle 14 homolog A (S. cerevisiae)
2.5 uridine phosphorylase 1
2.5 ephrin-B1
2.5 DnaJ (Hsp40) homolog, subfamily B, member 9
2.4 <no annotation>
2.4 nicotinamide N-methyltransferase
2.4 pannexin 1
2.4 v-rel reticuloendotheliosis viral oncogene homolog (avian)
2.4 C-type lectin-like receptor-1
2.4 tumor necrosis factor (ligand) superfamily, member 10
2.4 heat shock 27kDa protein 8
2.4 optineurin
2.4 TNF receptor-associated factor 3
2.4 MAD, mothers against decapentaplegic homolog 3 (Drosophila)
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2.4 zinc fingers and homeoboxes 2
2.4 interleukin 15 receptor, alpha
2.3 junctional adhesion molecule 2
2.3 hypothetical protein FLJ10276
2.3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
2.3 chromosome 6 open reading frame 197
2.3 opioid growth factor receptor-like 1
2.3 bone morphogenetic protein 2
2 3 protein tyrosine phosphatase, receptor type, K
2.2 guanylate binding protein 1, interferon-inducible, 67kDa
2.2 salvador homolog 1 (Drosophila)
2.2 hypothetical protein FLJ90440
2.2 PDZ and LIM domain 4
2.2 pentaxin-related gene, rapidly induced by IL-1 beta
2.2 TIR domain containing adaptor inducing interferon-beta
2.2 <no annotation>
2.2 hypothetical protein FLJ90005
2.2 B-cell CLL/lymphoma 6 (zinc finger protein 51)
2 2 <no annotation>
2 1 M025 protein
2.1 transducin-like enhancer of split 3 (E(spl) homolog, Drosophila)
2.1 START domain containing 10
2.1 CDC42 effector protein (Rho GTPase binding) 2
2.1 pleckstrin homology-like domain, family A, member 1
2.1 Kruppel-like factor 3 (basic)
2.1 phospholipase A2, group IVC (cytosolic, calcium-independent)
2.1 cylindromatosis (turban tumor syndrome)
2.1 solute carrier family 7, (cationic amino acid transporter, y+ system) member 11
2.1 <no annotation>
2.1 endothelial cell-specific molecule 1
2.1 matrix metalloproteinase 10 (stromelysin 2)
2.1 endothelial differentiation, sphingolipid G-protein-coupled receptor, 1
2 1 tubulin, beta polypeptide
2.0 selenoprotein SelM
2.0 tripartite motif-containing 56
2.0 KIAA1404 protein
2.0 <no annotation>
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2.0 serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 8
2.0 a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 4
2.0 tyrosylprotein sulfotransferase 1
2.0 SRY (sex determining region Y)-box 1
2.0 regulator of G-protein signalling 3
2.0 zinc finger protein, multitype 2
2.0 WD repeat endosomal protein
2.0 ubiquitous tetratricopeptide containing protein RoXaN
1.9 formin binding protein 1
1.9 LIM domain kinase 2
1.9 DKFZP586N0721 protein
1.9 <no annotation>
1.9 CASP8 and FADD-like apoptosis regulator
1.9 eukaryotic translation initiation factor 2C, 2
1.9 mitogen-activated protein kinase kinase 3
1.9 ras homolog gene family, member B
1.9 X-box binding protein 1
1.9 G protein-coupled receptor 56
1.9 <no annotation>
1.9 hypothetical protein FLJ22344
1.9 DnaJ (Hsp40) homolog, subfamily A, member 1
1.9 <no annotation>
1 .9 mitogen-activated protein kinase kinase kinase 7 interacting protein 2
1.9 mitogen-activated protein kinase kinase 3
1.9 nucleolar protein 1, 120kDa
1.9 guanylate binding protein 4
1.9 v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
1.9 Ras association (RalGDS/AF-6) domain family 1
1.9 monocyte to macrophage differentiation-associated
1.9 poliovirus receptor
1.8 <no annotation>
1.8 roundabout, axon guidance receptor, homolog 1 (Drosophila)
1.8 <no annotation>
1.8 stannin
1.8 tumor necrosis factor receptor superfamily, member 10b
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1.8 guanine nucleotide exchange factor for Rap1
1.8 TNFAIP3 interacting protein 2
1.8 phosphatidylinositol transfer protein, cytoplasmic 1
1.8 <no annotation>
1.8 <no annotation>
1.8 hypothetical protein MGC17791
1.8 GPP34-related protein
1.8 <no annotation>
1.8 cyclin-dependent kinase inhibitor 1A (p21, Cipl)
1.8 <no annotation>
1.8 melanoma differentiation associated protein-5
1.8 hypothetical protein FLJ12484
1.8 activated leukocyte cell adhesion molecule
1.8 transforming growth factor, beta receptor 11 (70/80kDa)
1.7 regulator of G-protein signalling 2, 24kDa
1.7 component of oligomeric golgi complex 3
1.7 myelin protein zero-like 1lhypothetical protein FLJ21047
1.7 signal transducer and activator of transcription 6, interleukin-4 induced
1.7 BCL2-related ovarian killer
1.7 tryptophanyl-tRNA synthetase
1.7 cysteine and glycine-rich protein 2
1.7 hypothetical protein MGC10986
1.7 pleckstrin homology domain containing, family C (with FERM domain) member 1
1.7 EH-domain containing 1
1.7 hepatocellular carcinoma related protein 1
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1.7 H2.0-like homeo box 1 (Drosophila)
1.7 promyelocytic leukemia
1.7 CD47 antigen (Rh-related antigen, integrin-associated signal transducer)
1.7 mitochondrial folate transporter/carrier
1.7 phosphatidic acid phosphatase type 2B
1.7 armadillo repeat protein ALEX2
1 .6 baculoviral AP repeat-containing 2
1.6 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5
1.6 cysteine-rich hydrophobic domain 2
1.6 dishevelled associated activator of morphogenesis 1
1.6 pleckstrin homology, Sec7 and coiled-coil domains (cytohesin 1)
1 .6 Wilms tumor 1 associated protein
1.6 transcription factor binding to IGHM enhancer 3
1.6 <no annotation>
1.6 mitogen-activated protein kinase kinase 1
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1.6 spermidine/spermine Nl-acetyltransferase
,,l 
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1.5 <no annotation>
1.4 tubulin, alpha 3
1.4 <no annotation>
-4.0 thioredoxin interacting protein
-3.0 DnaJ (Hsp4O) homolog, subfamily B, member 4
-3.0 thrombomodulin
-2.9 Kruppel-like factor 2 (lung)
-2.9 papillomavirus regulatory factor PRF-1 hypothetical protein DKFZp434K1210
-2.8 core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related
-2.8 adrenomedullin
-2.8 gap junction protein, alpha 4, 37kDa (connexin 37)
-2.8 SRY (sex determining region Y)-box 18
;-2.6 prickle-like . t .(Drosophila) (( 4 . i
-2.6 prickle-like 1 (Drosophila)
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-2.6
-2.5
-2.5
-2.5
-2.4
-2.4
Gene Name
G protein-coupled receptor 126
protein kinase, cAMP-dependent, catalytic, beta
Clq domain containing 1
hypothetical protein LOC51063
<no annotation>
Meisl, myeloid ecotropic viral integration site 1 homolog (mouse)
-2.4 Rho GTPase activating protein 18
-2.4 EH-domain containing 3
-2.4 lymphoblastic leukemia derived sequence 1
-2.3 palmdelphin
-2.3 mesenchymal stem cell protein DSCD75
-2.3 hypothetical protein FLJ20674
-2.3 chemokine-like factor super family 8
-2.2 <no annotation>
-2.1 dachshund homolog (Drosophila)
-2.1 calcitonin receptor-like
-2.1 <no annotation>
-2.0 v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
-2.0 scavenger receptor class F, member 2
-2.0 homeo box A10
-1 .9 LIM domain only 4
-1.9 early hematopoietic zinc finger
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-1 .9 interferon regulatory factor 2 binding protein 2
-1 .8 <no annotation>
-1 .8 immune associated nucleotide
-1 .8 <no annotation>
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-1 .6 connective tissue growth factor
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